<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
<journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLoS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31150472</article-id>
<article-id pub-id-type="pmc">6544350</article-id>
<article-id pub-id-type="publisher-id">PONE-D-18-29479</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0217620</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Computational Biology</subject>
<subj-group>
<subject>Genome Analysis</subject>
<subj-group>
<subject>Genome-Wide Association Studies</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genomics</subject>
<subj-group>
<subject>Genome Analysis</subject>
<subj-group>
<subject>Genome-Wide Association Studies</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Human Genetics</subject>
<subj-group>
<subject>Genome-Wide Association Studies</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Biochemistry</subject>
<subj-group>
<subject>Proteins</subject>
<subj-group>
<subject>Lipoproteins</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Vascular Medicine</subject>
<subj-group>
<subject>Atherosclerosis</subject>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Medicine and Health Sciences</subject>
<subj-group>
<subject>Clinical Genetics</subject>
<subj-group>
<subject>Genetic Diseases</subject>
<subj-group>
<subject>Autosomal Dominant Diseases</subject>
<subj-group>
<subject>Familial Hypercholesterolemia</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Database and Informatics Methods</subject>
<subj-group>
<subject>Bioinformatics</subject>
<subj-group>
<subject>Sequence Analysis</subject>
<subj-group>
<subject>Amino Acid Sequence Analysis</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Physical Sciences</subject>
<subj-group>
<subject>Chemistry</subject>
<subj-group>
<subject>Chemical Reactions</subject>
<subj-group>
<subject>Oxidation</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Research and Analysis Methods</subject>
<subj-group>
<subject>Database and Informatics Methods</subject>
<subj-group>
<subject>Bioinformatics</subject>
<subj-group>
<subject>Sequence Analysis</subject>
<subj-group>
<subject>Sequence Alignment</subject>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
</subj-group>
<subj-group subj-group-type="Discipline-v3">
<subject>Biology and Life Sciences</subject>
<subj-group>
<subject>Genetics</subject>
<subj-group>
<subject>Genetic Loci</subject>
</subj-group>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Multiple rare and common variants in <italic>APOB</italic> gene locus associated with oxidatively modified low-density lipoprotein levels</article-title>
<alt-title alt-title-type="running-head">Variants in <italic>APOB</italic> associated with oxidatively modified low-density lipoprotein levels</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8355-8960</contrib-id>
<name>
<surname>Khlebus</surname>
<given-names>Eleonora</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9844-3122</contrib-id>
<name>
<surname>Kutsenko</surname>
<given-names>Vladimir</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meshkov</surname>
<given-names>Alexey</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ershova</surname>
<given-names>Alexandra</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4765-8021</contrib-id>
<name>
<surname>Kiseleva</surname>
<given-names>Anna</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shevtsov</surname>
<given-names>Anton</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Software</role>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shcherbakova</surname>
<given-names>Natalia</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zharikova</surname>
<given-names>Anastasiia</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lankin</surname>
<given-names>Vadim</given-names>
</name>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tikhaze</surname>
<given-names>Alla</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chazova</surname>
<given-names>Irina</given-names>
</name>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yarovaya</surname>
<given-names>Elena</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Drapkina</surname>
<given-names>Oksana</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boytsov</surname>
<given-names>Sergey</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff001">
<label>1</label>
<addr-line>Federal State Institution National Medical Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation, Moscow, Russia</addr-line>
</aff>
<aff id="aff002">
<label>2</label>
<addr-line>Moscow Institute of Physics and Technology (State University), Moscow, Russia</addr-line>
</aff>
<aff id="aff003">
<label>3</label>
<addr-line>Lomonosov Moscow State University, Moscow, Russia</addr-line>
</aff>
<aff id="aff004">
<label>4</label>
<addr-line>Federal State Budget Organization National Medical Research Center of Cardiology of the Ministry of Healthcare of the Russian Federation, Moscow, Russia</addr-line>
</aff>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Thameem</surname>
<given-names>Farook</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"></xref>
</contrib>
</contrib-group>
<aff id="edit1">
<addr-line>University of Texas Health Science Center at San Antonio, UNITED STATES</addr-line>
</aff>
<author-notes>
<fn fn-type="COI-statement" id="coi001">
<p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email>eleonora.khlebus@phystech.edu</email></corresp>
</author-notes>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>14</volume>
<issue>5</issue>
<elocation-id>e0217620</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>5</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 Khlebus et al</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Khlebus et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="pone.0217620.pdf"></self-uri>
<abstract>
<p>Oxidatively modified low-density lipoproteins (oxLDL) play an important role in the occurrence and progression of atherosclerosis. To identify the genetic factors influencing the oxLDL levels, we have genotyped 776 DNA samples of Russian individuals for 196,725 single-nucleotide polymorphisms (SNPs) using the Cardio-MetaboChip (Illumina, USA) and conducted genome-wide association study (GWAS). Fourteen common variants in the locus including <italic>APOB</italic> gene were significantly associated with the oxLDL levels (<italic>P</italic> &lt; 2.18 × 10<sup>−7</sup>). These variants explained only 6% of the variation in the oxLDL levels. Then, we assessed the contribution of rare coding variants of <italic>APOB</italic> gene to the oxLDL levels. Individuals with the extreme oxLDL levels (48 with the lowest and 48 with the highest values) were selected for targeted sequencing of the region including <italic>APOB</italic> gene. To evaluate the contribution of the SNPs to the oxLDL levels we used various statistical methods for the association analysis of rare variants: WST, SKAT, and SKAT-O. We revealed that both synonymous and nonsynonymous SNPs affected the oxLDL levels. For the joint analysis of the rare and common variants, we conducted the SKAT-C testing and found a group of 15 SNPs significantly associated with the oxLDL levels (<italic>P</italic> = 2.14 × 10<sup>−9</sup>). Our results indicate that the oxLDL levels depend on both common and rare variants of the <italic>APOB</italic> gene.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100006769</institution-id>
<institution>Russian Science Foundation</institution>
</institution-wrap>
</funding-source>
<award-id>14-15-00245</award-id>
<principal-award-recipient>
<name>
<surname>Lankin</surname>
<given-names>Vadim</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This research was supported by grant of Russian Scientific Foundation 14-15-00245.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="3"></table-count>
<page-count count="20"></page-count>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>Data set containing fragment coordinates for TargetSeq Custom Enrichment Kit which was designed to target sequencing the region containing the complete genomic sequence of the APOB gene in locus 2p24-p23 (chr2: 20996301-21494945; GRCh37/hg19 reference human genome) are within the Supporting Information files. Public sharing of other data presented in the article is limited by law in Russia. According to the Article 12 «Сross-border data transmission» of Federal Law of July 27, 2006 No.152 "Concerning Personal Data" (updated to September 1, 2015), we are not able to transfer the data. Data requests may be sent to Biobank at the National Medical Research Center for Preventative Medicine (<email>biobank@gnicpm.ru</email>), the corresponding author Eleonora Khlebus (<email>eleonora.khlebus@phystech.edu</email>), or principal investigator and head of the data steering committee Alexey Meshkov (<email>meshkov@lipidclinic.ru</email>).</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<title>Data Availability</title>
<p>Data set containing fragment coordinates for TargetSeq Custom Enrichment Kit which was designed to target sequencing the region containing the complete genomic sequence of the APOB gene in locus 2p24-p23 (chr2: 20996301-21494945; GRCh37/hg19 reference human genome) are within the Supporting Information files. Public sharing of other data presented in the article is limited by law in Russia. According to the Article 12 «Сross-border data transmission» of Federal Law of July 27, 2006 No.152 "Concerning Personal Data" (updated to September 1, 2015), we are not able to transfer the data. Data requests may be sent to Biobank at the National Medical Research Center for Preventative Medicine (<email>biobank@gnicpm.ru</email>), the corresponding author Eleonora Khlebus (<email>eleonora.khlebus@phystech.edu</email>), or principal investigator and head of the data steering committee Alexey Meshkov (<email>meshkov@lipidclinic.ru</email>).</p>
</notes>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Atherosclerosis is a complex multifactorial disease that is a major cause of cardiovascular disorders and a leading cause of mortality in developed countries. Over the last few decades, it was also suggested that the low density lipoprotein (LDL) oxidation plays an important role in the development and progression of atherosclerosis and its complications [<xref ref-type="bibr" rid="pone.0217620.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0217620.ref004">4</xref>].</p>
<p>Under oxidative stress, accompanying the atherosclerosis development, the oxidized (lipoperoxides-containing) and/or oxidatively modified (containing the apoprotein modified by the secondary oxidation products—dicarbonyls) LDL particles accumulate in plasma [<xref ref-type="bibr" rid="pone.0217620.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0217620.ref004">4</xref>]. The oxidatively modified LDL (unlike oxidized LDL) is actively captured by macrophages, leading to the formation of the lipid enriched foam cells [<xref ref-type="bibr" rid="pone.0217620.ref005">5</xref>].</p>
<p>Previously, by performing the genome-wide association study (GWAS) in the Finnish population, it was shown that the oxLDL levels can be genetically determined [<xref ref-type="bibr" rid="pone.0217620.ref006">6</xref>]. However, human GWASs have important limitations. GWASs are typically focused on the common genetic variants with the minor allele frequency (MAF) greater than 0.05 and even the very large GWASs explain only a small fraction of the estimated heritability [<xref ref-type="bibr" rid="pone.0217620.ref007">7</xref>]. In the previously mentioned GWAS, the top significant SNP (rs676210) explained only 11% of the variation in the oxLDL [<xref ref-type="bibr" rid="pone.0217620.ref006">6</xref>]. In the current research, we have replicated the significant associations in an independent study of a Russian cohort and explained only 6% of the variation in the oxLDL levels.</p>
<p>One of the possible explanation of the ‘missing heritability’ is given by an underestimation of rare variants [<xref ref-type="bibr" rid="pone.0217620.ref008">8</xref>–<xref ref-type="bibr" rid="pone.0217620.ref010">10</xref>]. An association study of the low-frequency and rare coding variants with the blood lipids and coronary heart disease was performed previously [<xref ref-type="bibr" rid="pone.0217620.ref011">11</xref>]. The contribution of the rare variants to the low levels of high density lipoprotein (HDL) cholesterol was studied [<xref ref-type="bibr" rid="pone.0217620.ref012">12</xref>]. Targeted sequencing studies in subjects with the low cholesterol levels detected the rare mutations in <italic>LDLR</italic> [<xref ref-type="bibr" rid="pone.0217620.ref013">13</xref>], <italic>PCSK9</italic> [<xref ref-type="bibr" rid="pone.0217620.ref014">14</xref>], and <italic>NPC1L1</italic> [<xref ref-type="bibr" rid="pone.0217620.ref015">15</xref>] genes. Also, an effect of common and rare gene variants on plasma LDL cholesterol was assessed [<xref ref-type="bibr" rid="pone.0217620.ref016">16</xref>]. However, the distinct role of rare variants in the LDL oxidation has yet to be understood as well as their potential role in atherosclerosis. Therefore, to fill the heritability gap, we have verified the hypothesis that the rare (MAF&lt;0.01) or low-frequency variants (MAF 0.01–0.05), which are not well covered by GWASs and not easily imputed, are also associated with the oxLDL levels.</p>
<p>To assess the contribution of the SNPs with the low MAF, the variants aggregation tests were developed. Instead of testing each SNP individually, these tests evaluate the cumulative effects of variants [<xref ref-type="bibr" rid="pone.0217620.ref017">17</xref>]. In our work, to find an association between the genetic variants and the oxLDL levels, we used the weighted-sum test (WST) [<xref ref-type="bibr" rid="pone.0217620.ref018">18</xref>], approaches based on the sequence kernel association test (SKAT) [<xref ref-type="bibr" rid="pone.0217620.ref019">19</xref>–<xref ref-type="bibr" rid="pone.0217620.ref022">22</xref>] and the adaptive combination of <italic>P</italic>-values method (ADA) [<xref ref-type="bibr" rid="pone.0217620.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0217620.ref024">24</xref>].</p>
<p>Here, we present the first results on a GWAS with oxLDL levels in Russian cohort. Furthermore, we report the association between the oxLDL levels and coding variants identified in <italic>APOB</italic> gene in the groups of patients with the extreme low and high oxLDL levels. Thus, for the first time in literature, we show the contribution of the common SNPs, as well as of the low-frequency and rare variants, to the oxLDL levels.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and methods</title>
<p>For more information, see <xref ref-type="supplementary-material" rid="pone.0217620.s008">S1 Appendix</xref>.</p>
<sec id="sec003">
<title>Study subjects</title>
<p>Study subjects were recruited from the Russian study “Approbation and implementation of new approaches to prevention, diagnosis, and treatment of atherosclerosis in outpatient settings by the example of the Western Administrative District of Moscow” from August to December 2009. OxLDL levels were measured for 776 patients with various cardiovascular risk according to the SCORE [<xref ref-type="bibr" rid="pone.0217620.ref025">25</xref>], these patients were selected for genotyping and GWAS analysis. DNA samples from 48 individuals with the highest oxLDL levels and 48 individuals with the lowest oxLDL levels out of total cohort were selected for targeted sequencing (<xref ref-type="fig" rid="pone.0217620.g001">Fig 1</xref>). The study was approved by the Russian Cardiology Research and Production Complex, A.L. Myasnikov Institute of Clinical Cardiology (Committee on the Ethics issues in clinical cardiology, protocol No.144, 27 April 2009). Written informed consent was obtained from all participants after approval by the ethical committee.</p>
<fig id="pone.0217620.g001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0217620.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Cohort diagram indicating a number of patients participating into different steps of research.</title>
</caption>
<graphic xlink:href="pone.0217620.g001"></graphic>
</fig>
</sec>
<sec id="sec004">
<title>Laboratory tests</title>
<p>Blood samples were taken from each of the subjects in the morning after he or she had fasted overnight. Circulating serum oxLDL levels were assayed by Oxidized LDL ELISA kit (Mercodia, Sweden) according to the protocol [<xref ref-type="bibr" rid="pone.0217620.ref026">26</xref>].</p>
<p>Atherosclerosis progression is accompanied by oxidative stress, while malondialdehyde (MDA) and other low molecular weight dicarbonyls can accumulate in blood plasma, including MDA homologue glyoxal and MDA isomer methylglyoxal [<xref ref-type="bibr" rid="pone.0217620.ref004">4</xref>]. Glyoxal and methylglyoxal, like MDA, can cause the atherogenic modification of LDL [<xref ref-type="bibr" rid="pone.0217620.ref004">4</xref>, <xref ref-type="bibr" rid="pone.0217620.ref026">26</xref>, <xref ref-type="bibr" rid="pone.0217620.ref027">27</xref>]. Previously we have determined that by using Oxidized LDL ELISA kit (Mercodia, Sweden) we can measure not any oxidized LDL, but mainly MDA-modified LDL (<xref ref-type="supplementary-material" rid="pone.0217620.s001">S1 Fig</xref>) [<xref ref-type="bibr" rid="pone.0217620.ref028">28</xref>]. Further under oxidatively modified LDL (oxLDL) we mean only these MDA-modified LDL.</p>
<p>Total cholesterol (TC), triglycerides (TG), HDL, apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB), high-sensitivity C-reactive protein (CRP), and lipoprotein (a) levels were measured using an automatic biochemistry analyzer ARCHITECT c8000 (Abbott Laboratories, USA). LDL was calculated according to the Friedewald formula [<xref ref-type="bibr" rid="pone.0217620.ref029">29</xref>] and in the case of TG&gt;4.5 mmol/l LDL was estimated by the direct method using the same analyzer ARCHITECT c8000.</p>
</sec>
<sec id="sec005">
<title>Measurement of intima-medial thickness and plaque parameters</title>
<p>High-resolution B-mode ultrasonography was performed with a 11-3 MHz linear-type probe (PHILIPS iE33 ultrasound system, Philips Inc., Eindhoven, Netherlands). All measurements were taken in the common carotid artery, carotid bulb and proximal segment of internal carotid artery. Three different longitudinal views (anterior oblique, lateral, and posterior oblique) of both carotid systems and transverse views of all plaques were obtained. A more detailed procedure was described in an earlier publication [<xref ref-type="bibr" rid="pone.0217620.ref030">30</xref>]. The individual value of mean intima-medial thickness (mean-IMT) was the mean of mean-IMTs of the right and left carotid arteries.</p>
<p>The presence of atherosclerotic plaque was estimated at 6 sites of carotid pool: the whole length of both common carotid arteries, both bifurcations, and both internal carotid arteries. Plaque was defined as a focal structure that encroached into the arterial lumen by at least 0.5 mm or 50% of the surrounding IMT value or demonstrated a thickness of ≥ 1.5 mm as measured from the media-adventitia interface to the intima-lumen interface [<xref ref-type="bibr" rid="pone.0217620.ref031">31</xref>]. Plaque number was defined as the sum total of the plaques. An individual value of total stenosis was defined as a sum of maximum reductions in the percent diameter stenosis of all carotid plaques.</p>
</sec>
<sec id="sec006">
<title>Microarray-based genotyping and quality control</title>
<p>Genotyping was performed by using Cardio-MetaboChip (Illumina, USA), designed to test 196,725 SNPs. Quality control for patients and SNPs was conducted by PLINK (v 1.07) [<xref ref-type="bibr" rid="pone.0217620.ref032">32</xref>]. SNPs which passed quality control had parameters: call rate &gt;0.95, MAF &gt;0.05, Hardy-Weinberg equilibrium <italic>P</italic> &gt; 1.0 × 10<sup>−5</sup>. Also, we excluded duplicates or probable relatives based on pairwise identity by state (PI_HAT &gt; 0.185) and samples with heterozygosity rates more than 3 s.d. from the mean. To determine whether our sequence variations were caused by the population stratification, we assayed genotyping data using the principal component analysis (PCA). The PCA revealed no evidence of differences in genetic ancestry between samples (<xref ref-type="supplementary-material" rid="pone.0217620.s002">S2 Fig</xref>).</p>
</sec>
<sec id="sec007">
<title>Target enrichment and DNA sequencing</title>
<p>Targeted sequencing was performed using the TargetSeq Custom Enrichment Kit (Thermo Fisher Scientific, USA) on the SOLiD 5500W system (Thermo Fisher Scientific, USA) according to the manufacturer’s protocol. TargetSeq Custom Enrichment Kit was designed to target the region containing the complete genomic sequence of the <italic>APOB</italic> gene in locus 2p24-p23 (chr2: 20996301-21494945; GRCh37/hg19 reference human genome). The kit consists of 536 fragments accounting for a total of 391 833 bp. Unique probes were designed using the Sequence Search and Alignment by Hashing Algorithm (SSAHA) [<xref ref-type="bibr" rid="pone.0217620.ref033">33</xref>]. Capture design coordinates are provided in <xref ref-type="supplementary-material" rid="pone.0217620.s007">S1 Dataset</xref>.</p>
</sec>
<sec id="sec008">
<title>Variant calling, postprocessing, and multiple alignment</title>
<p>Mapping and variant calling were performed with LifeScope Genomic Analysis Software for SOLiD Next-Generation Sequencing (GRCh37/hg19 reference human genome). We used Samtools [<xref ref-type="bibr" rid="pone.0217620.ref034">34</xref>] for duplicate reads removal. To get coverage data we used BedTools [<xref ref-type="bibr" rid="pone.0217620.ref035">35</xref>]. We filtered variants using 10x coverage threshold. Each base with low-quality (Phred score &lt; 30) sequence was also removed. Value 30 means that read assigned a Phred mapping quality with this score has a 1 in 1000 chance of being misaligned [<xref ref-type="bibr" rid="pone.0217620.ref036">36</xref>]. We used ANNOVAR software [<xref ref-type="bibr" rid="pone.0217620.ref037">37</xref>] for SNPs annotation. Functional effects of the detected variants were assessed with the SIFT [<xref ref-type="bibr" rid="pone.0217620.ref038">38</xref>] and PolyPhen-2 [<xref ref-type="bibr" rid="pone.0217620.ref039">39</xref>] algorithms. Multiple protein alignment was obtained using MUSCLE [<xref ref-type="bibr" rid="pone.0217620.ref040">40</xref>] and visualized using Jalview [<xref ref-type="bibr" rid="pone.0217620.ref041">41</xref>].</p>
</sec>
<sec id="sec009">
<title>Statistical analysis</title>
<p>Univariable statistical analysis was performed with Statistica v.8.0. <italic>P</italic>-value of less than 0.05 was considered to be statistically significant. Data were presented as median (25th–75th percentile). <italic>P</italic>-value for quantitative parameters was calculated using a non-parametric Mann-Whitney test. <italic>P</italic>-value for quality parameters was calculated using Yates’ corrected <italic>χ</italic><sup>2</sup> test. If the sample size included five subjects or fewer, a two-tailed Fisher’s exact test was used. Correlation analysis was performed by Spearman’s rank correlation test. For estimation of variation in the oxLDL levels non-adjusted R<sup>2</sup> was used.</p>
<p>Association of common SNPs, obtained by microarray genotyping, with oxLDL levels in GWAS was tested using the PLINK software (v 1.07) [<xref ref-type="bibr" rid="pone.0217620.ref032">32</xref>]. Also, we examined the SNPs association with the other parameters: oxLDL/LDL and oxLDL/ApoB ratios, TC, TG, LDL, HDL, CRP, ApoA1 and ApoB.</p>
<p>For the analysis of rare and low-frequency variants obtained by targeted sequencing, we used weighted-sum test (WST) [<xref ref-type="bibr" rid="pone.0217620.ref018">18</xref>] and sequence kernel association test (SKAT) [<xref ref-type="bibr" rid="pone.0217620.ref019">19</xref>]. Also, we used optimal SKAT (SKAT-O) method which is based on combination of burden test and SKAT [<xref ref-type="bibr" rid="pone.0217620.ref020">20</xref>]. As covariates we used age, sex, smoking status, body mass index, waist, HDL, CRP, lipoprotein (a), hypertension, myocardial infarction, diabetes mellitus, stroke, and statins use. For the joint analysis of rare, low-frequency and common variants, we applied combined SKAT (SKAT-C) [<xref ref-type="bibr" rid="pone.0217620.ref021">21</xref>]. For the analysis of rare and low-frequency variants by WST we used the custom script in programming language R, for methods SKAT, SKAT-O and SKAT-C R-package [<xref ref-type="bibr" rid="pone.0217620.ref042">42</xref>]. Variants selection was performed by using results of adaptive combination of <italic>P</italic>-values (ADA) method [<xref ref-type="bibr" rid="pone.0217620.ref024">24</xref>] and SKAT backward elimination (BE-SKAT) test [<xref ref-type="bibr" rid="pone.0217620.ref022">22</xref>]. To select a subgroup of associated variants, as suggested at [<xref ref-type="bibr" rid="pone.0217620.ref043">43</xref>], we used the elastic net [<xref ref-type="bibr" rid="pone.0217620.ref044">44</xref>] from R-package [<xref ref-type="bibr" rid="pone.0217620.ref045">45</xref>] with AUC-ROC-based cross-validation.</p>
</sec>
</sec>
<sec id="sec010" sec-type="conclusions">
<title>Results and discussion</title>
<sec id="sec011">
<title>GWAS for finding variants affecting the oxLDL levels</title>
<p>We studied 776 DNA samples of Russian individuals with measured oxLDL levels for 196,725 SNPs genotyped by the Cardio-MetaboChip (Illumina, USA). Based on the quality control, we selected 725 patients and 101,704 SNPs. Clinical and laboratory characteristics of the patients are shown in <xref ref-type="table" rid="pone.0217620.t001">Table 1</xref>. Under oxLDL we mean the MDA-modified LDL [<xref ref-type="bibr" rid="pone.0217620.ref028">28</xref>].</p>
<table-wrap id="pone.0217620.t001" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0217620.t001</object-id>
<label>Table 1</label>
<caption>
<title>Characteristics of 725 patients cohort and individuals with low and high oxLDL levels.</title>
</caption>
<alternatives>
<graphic id="pone.0217620.t001g" xlink:href="pone.0217620.t001"></graphic>
<table border="0" frame="box" rules="all">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">Parameter</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">Total cohort, n = 725</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">Low oxLDL levels group, n = 48</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">High oxLDL levels group, n = 48</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick"><italic>P</italic>-value<xref ref-type="table-fn" rid="t001fn002">*</xref></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age, years</td>
<td align="left" colspan="1" rowspan="1">57 (51-63)</td>
<td align="left" colspan="1" rowspan="1">59 (50-64)</td>
<td align="left" colspan="1" rowspan="1">56 (51-62)</td>
<td align="left" colspan="1" rowspan="1">0.703</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Men, n (%)</td>
<td align="left" colspan="1" rowspan="1">206 (28.4)</td>
<td align="left" colspan="1" rowspan="1">21 (43.8)</td>
<td align="left" colspan="1" rowspan="1">17 (35.4)</td>
<td align="left" colspan="1" rowspan="1">0.531</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Smoking, n (%)</td>
<td align="left" colspan="1" rowspan="1">108 (14.9)</td>
<td align="left" colspan="1" rowspan="1">7 (14.6)</td>
<td align="left" colspan="1" rowspan="1">12 (25.0)</td>
<td align="left" colspan="1" rowspan="1">0.306</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BMI, kg/m2</td>
<td align="left" colspan="1" rowspan="1">28.7 (25.8-32.2)</td>
<td align="left" colspan="1" rowspan="1">28.7 (24.9-31.2)</td>
<td align="left" colspan="1" rowspan="1">28.3 (26.1-32.0)</td>
<td align="left" colspan="1" rowspan="1">0.613</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Waist, cm</td>
<td align="left" colspan="1" rowspan="1">93 (84-102)</td>
<td align="left" colspan="1" rowspan="1">94 (84-101)</td>
<td align="left" colspan="1" rowspan="1">90 (85-102)</td>
<td align="left" colspan="1" rowspan="1">0.946</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total cholesterol, mmol/l</td>
<td align="left" colspan="1" rowspan="1">5.90 (5.17-6.88)</td>
<td align="left" colspan="1" rowspan="1">4.25 (3.90-4.88)</td>
<td align="left" colspan="1" rowspan="1">7.66 (7.01-8.25)</td>
<td align="left" colspan="1" rowspan="1">1.17 × 10<sup>−14</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Triglycerides, mmol/l</td>
<td align="left" colspan="1" rowspan="1">1.60 (1.14-2.19)</td>
<td align="left" colspan="1" rowspan="1">1.22 (0.84-1.71)</td>
<td align="left" colspan="1" rowspan="1">2.20 (1.67-2.91)</td>
<td align="left" colspan="1" rowspan="1">1.55 × 10<sup>−7</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LDL, mmol/l</td>
<td align="left" colspan="1" rowspan="1">3.60 (2.92-4.39)</td>
<td align="left" colspan="1" rowspan="1">2.31 (1.90-2.60)</td>
<td align="left" colspan="1" rowspan="1">4.86 (3.93-5.61)</td>
<td align="left" colspan="1" rowspan="1">2.04 × 10<sup>−14</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HDL, mmol/l</td>
<td align="left" colspan="1" rowspan="1">1.34 (1.14-1.58)</td>
<td align="left" colspan="1" rowspan="1">1.29 (1.10-1.50)</td>
<td align="left" colspan="1" rowspan="1">1.20 (1.06-1.48)</td>
<td align="left" colspan="1" rowspan="1">0.322</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Apolipoprotein B, mg/dl</td>
<td align="left" colspan="1" rowspan="1">102 (87-123)</td>
<td align="left" colspan="1" rowspan="1">72 (64-80)</td>
<td align="left" colspan="1" rowspan="1">142 (125-154)</td>
<td align="left" colspan="1" rowspan="1">7.88 × 10<sup>−14</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Apolipoprotein A1, mg/dl</td>
<td align="left" colspan="1" rowspan="1">162 (144-184)</td>
<td align="left" colspan="1" rowspan="1">151 (139-176)</td>
<td align="left" colspan="1" rowspan="1">161 (141-181)</td>
<td align="left" colspan="1" rowspan="1">0.347</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Lipoprotein (a), mg/dl</td>
<td align="left" colspan="1" rowspan="1">11.4 (5.2-33.5)</td>
<td align="left" colspan="1" rowspan="1">8.1 (3.4-22.8)</td>
<td align="left" colspan="1" rowspan="1">13.4 (6.2-33.4)</td>
<td align="left" colspan="1" rowspan="1">0.078</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">oxLDL, U/dl</td>
<td align="left" colspan="1" rowspan="1">68.50 (55.72-85.64)</td>
<td align="left" colspan="1" rowspan="1">35.29 (31.02-39.64)</td>
<td align="left" colspan="1" rowspan="1">118.35 (113.47-124.12)</td>
<td align="left" colspan="1" rowspan="1">3.15 × 10<sup>−17</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">oxLDL/LDL, U/dl per mmol per l</td>
<td align="left" colspan="1" rowspan="1">19.32 (16.21-23.00)</td>
<td align="left" colspan="1" rowspan="1">15.75 (12.64-18.53)</td>
<td align="left" colspan="1" rowspan="1">23.79 (20.87-28.00)</td>
<td align="left" colspan="1" rowspan="1">8.49 × 10<sup>−13</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">oxLDL/ApoB, U/dl per mg per dl</td>
<td align="left" colspan="1" rowspan="1">0.67 (0.56-0.78)</td>
<td align="left" colspan="1" rowspan="1">0.48 (0.42-0.55)</td>
<td align="left" colspan="1" rowspan="1">0.82 (0.75-1.01)</td>
<td align="left" colspan="1" rowspan="1">4.05 × 10<sup>−15</sup></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CRP, mg/dl</td>
<td align="left" colspan="1" rowspan="1">0.24 (0.13-0.42)</td>
<td align="left" colspan="1" rowspan="1">0.19 (0.09-0.37)</td>
<td align="left" colspan="1" rowspan="1">0.28 (0.16-0.45)</td>
<td align="left" colspan="1" rowspan="1">0.031</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hypertension, n (%)</td>
<td align="left" colspan="1" rowspan="1">586 (80.8)</td>
<td align="left" colspan="1" rowspan="1">39 (81.3)</td>
<td align="left" colspan="1" rowspan="1">37 (77.1)</td>
<td align="left" colspan="1" rowspan="1">0.802</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Myocardial infarction, n (%)</td>
<td align="left" colspan="1" rowspan="1">71 (9.8)</td>
<td align="left" colspan="1" rowspan="1">7 (14.6)</td>
<td align="left" colspan="1" rowspan="1">7 (14.6)</td>
<td align="left" colspan="1" rowspan="1">0.772</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Diabetes mellitus, n (%)</td>
<td align="left" colspan="1" rowspan="1">113 (15.6)</td>
<td align="left" colspan="1" rowspan="1">9 (18.8)</td>
<td align="left" colspan="1" rowspan="1">6 (12.5)</td>
<td align="left" colspan="1" rowspan="1">0.544</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Stroke, n (%)</td>
<td align="left" colspan="1" rowspan="1">16 (2.2)</td>
<td align="left" colspan="1" rowspan="1">3 (6.3)</td>
<td align="left" colspan="1" rowspan="1">4 (8.3)</td>
<td align="left" colspan="1" rowspan="1">1.000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Statins, n (%)</td>
<td align="left" colspan="1" rowspan="1">163 (22.5)</td>
<td align="left" colspan="1" rowspan="1">19 (39.6)</td>
<td align="left" colspan="1" rowspan="1">13 (27.1)</td>
<td align="left" colspan="1" rowspan="1">0.279</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total stenosis, %</td>
<td align="left" colspan="1" rowspan="1">80 (25-130)</td>
<td align="left" colspan="1" rowspan="1">63 (23-115)</td>
<td align="left" colspan="1" rowspan="1">75 (25-150)</td>
<td align="left" colspan="1" rowspan="1">0.362</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Plaque number</td>
<td align="left" colspan="1" rowspan="1">3 (1-4)</td>
<td align="left" colspan="1" rowspan="1">2 (1-4)</td>
<td align="left" colspan="1" rowspan="1">3 (1-5)</td>
<td align="left" colspan="1" rowspan="1">0.315</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mean-IMT, mm</td>
<td align="left" colspan="1" rowspan="1">0.71 (0.62-0.85)</td>
<td align="left" colspan="1" rowspan="1">0.71 (0.63-0.85)</td>
<td align="left" colspan="1" rowspan="1">0.71 (0.61-0.86)</td>
<td align="left" colspan="1" rowspan="1">0.916</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001">
<p>BMI—body mass index, LDL—low-density lipoprotein, HDL—high-density lipoprotein, CRP—high-sensitivity C-reactive protein, oxLDL—oxidatively modified low-density lipoprotein, ApoB—Apolipoprotein B, Mean-IMT—mean intima-medial thickness. Data are presented as numbers (percentages) in cases of categorical data and median (25th–75th percentile) in cases of continuous data.</p>
</fn>
<fn id="t001fn002">
<p>* <italic>P</italic>-value (difference between low and high oxLDL levels groups) for quantitative parameters was calculated for non-parametric Mann-Whitney test, for quality parameters <italic>P</italic>-value was calculated using two-tailed Fisher’s exact test if it is available, otherwise—for Yates’ corrected <italic>χ</italic><sup>2</sup> test.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The oxLDL levels varied from 21.03 to 163.72 U/dl (with the median of 68.5) and correlated with the levels of the TC, TG, LDL, CRP and ApoB, and with the ultrasound markers of atherosclerosis (<xref ref-type="supplementary-material" rid="pone.0217620.s009">S1 Table</xref>). GWAS analysis was performed for oxLDL levels and for biochemical parameters correlated with it.</p>
<p>The Manhattan plot (<xref ref-type="fig" rid="pone.0217620.g002">Fig 2</xref>), quantile-quantile plot (<xref ref-type="supplementary-material" rid="pone.0217620.s003">S3 Fig</xref>) and regional plot (<xref ref-type="supplementary-material" rid="pone.0217620.s004">S4 Fig</xref>) [<xref ref-type="bibr" rid="pone.0217620.ref046">46</xref>] illustrate the results of the association analyses performed for the oxLDL levels. We identified 14 significant SNPs (<italic>P</italic> &lt; 2.18 × 10<sup>−7</sup>) on the chromosome 2 (<xref ref-type="supplementary-material" rid="pone.0217620.s010">S2 Table</xref>). Twelve out of fourteen significant variants were localized in the intronic regions of <italic>APOB</italic> gene and in the intergenic regions near this gene. Other two SNPs were <italic>APOB</italic> nonsynonymous (NS) exonic variants: rs1042034 (p.Ser4338Asn) and rs676210 (p.Pro2739Leu). The association of the variants from chromosome 2 with the oxLDL/LDL and oxLDL/ApoB ratios was also found. GWAS results for other biochemical parameters were not significant in this study.</p>
<fig id="pone.0217620.g002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0217620.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Manhattan plot of GWAS results showing highest SNPs associated with oxLDL levels.</title>
<p>The dots represent the SNPs organized by the chromosomal order and position. The y–axis describes the statistical significance (expressed as −<italic>log</italic>10 of the <italic>P</italic>-values).</p>
</caption>
<graphic xlink:href="pone.0217620.g002"></graphic>
</fig>
<p>All 14 significant SNPs, found in our study and associated with the oxLDL levels, are in concordance with the variants obtained earlier in the Finnish population and replicated in the German cohorts [<xref ref-type="bibr" rid="pone.0217620.ref006">6</xref>]. In the latter study, only one independent SNP (rs676210) was declared as a true functional variant, which explained only 11% of the oxLDL variation. Present study showed that our significant variants explained only 6% of oxLDL variation (<italic>R</italic><sup>2</sup> = 6%). To this end, we suggested that the rare and low-frequency variants could be crucial for the LDL oxidation. We used the targeted sequencing of <italic>APOB</italic> gene locus to find other functional variants explaining an additional variation in the oxLDL levels.</p>
</sec>
<sec id="sec012">
<title>Targeted sequencing for finding variants of <italic>APOB</italic></title>
<p>For this part of our study, we selected those 96 patients out of 725 individuals who had an extremely high (H group) and low (L group) oxLDL levels: 48 individuals with the lowest oxLDL levels (with the median of 35.29 U/dl) and 48 individuals with the highest ones (with the median of 118.35 U/dl). These groups differed significantly by oxLDL levels (<italic>P</italic> = 3.15 × 10<sup>−17</sup> by <italic>χ</italic><sup>2</sup> test). H group was matched to the L group with respect to age, sex, smoking status, body mass index, waist, levels of HDL, ApoA1, and lipoprotein (a). The patients were also matched for the prevalence of hypertension, myocardial infarction, diabetes mellitus, stroke, and statin use. The severity of carotid atherosclerosis according to the results of carotid ultrasound were comparable between the study groups. Individuals from H group demonstrated significantly higher levels of TC, TG, LDL, ApoB, and CRP. The characteristics of two groups are provided in <xref ref-type="table" rid="pone.0217620.t001">Table 1</xref>.</p>
<p>For targeted sequencing we designed the locus 2p24-p23 which included <italic>APOB</italic> gene (chr2: 20996301-21494945; GRCh37/hg19 reference human genome) and 14 significant variants according to our GWAS analysis. We conducted a targeted sequencing of designed locus and identified a total of 1,992 SNPs; 30 SNPs were exonic (<xref ref-type="table" rid="pone.0217620.t002">Table 2</xref>) with 23 SNPs leading to the NS amino acid change including one nonsense mutation.</p>
<table-wrap id="pone.0217620.t002" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0217620.t002</object-id>
<label>Table 2</label>
<caption>
<title>Exonic SNPs of <italic>APOB</italic> found by targeted sequencing in patients with high and low oxLDL levels.</title>
</caption>
<alternatives>
<graphic id="pone.0217620.t002g" xlink:href="pone.0217620.t002"></graphic>
<table border="0" frame="box" rules="all">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">Genomic position (GRCh37/ hg19)</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">Exon</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">Amino acid change</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">SNP ID</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">SIFT/ Poly-Phen-2</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">MAF (ExAC)</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick"><xref ref-type="table-fn" rid="t002fn003">**</xref>Low group</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick"><xref ref-type="table-fn" rid="t002fn003">**</xref>High group</th>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick">Previously published with respect to</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">21224853</td>
<td align="left" colspan="1" rowspan="1">29</td>
<td align="left" colspan="1" rowspan="1">p.Ala4481Thr</td>
<td align="left" colspan="1" rowspan="1">rs1801695</td>
<td align="left" colspan="1" rowspan="1">D / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.02407</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">HDL [<xref ref-type="bibr" rid="pone.0217620.ref047">47</xref>]; oxLDL [<xref ref-type="bibr" rid="pone.0217620.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0217620.ref028">28</xref>]; Dementia [<xref ref-type="bibr" rid="pone.0217620.ref048">48</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21224854<xref ref-type="table-fn" rid="t002fn002">*</xref></td>
<td align="left" colspan="1" rowspan="1">29</td>
<td align="left" colspan="1" rowspan="1">p.Gln4480Gln</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1">0.000008267</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21224907</td>
<td align="left" colspan="1" rowspan="1">29</td>
<td align="left" colspan="1" rowspan="1">p.Lys4463Glu</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">D / B</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21225119</td>
<td align="left" colspan="1" rowspan="1">29</td>
<td align="left" colspan="1" rowspan="1">p.Ser4392Asn</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.00004974</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">Familial hypercholesterolemia [<xref ref-type="bibr" rid="pone.0217620.ref049">49</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21225281</td>
<td align="left" colspan="1" rowspan="1">29</td>
<td align="left" colspan="1" rowspan="1">p.Ser4338Asn</td>
<td align="left" colspan="1" rowspan="1">rs1042034</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.7057</td>
<td align="left" colspan="1" rowspan="1">7,24,17</td>
<td align="left" colspan="1" rowspan="1">1,6,41</td>
<td align="left" colspan="1" rowspan="1">HDL, TG [<xref ref-type="bibr" rid="pone.0217620.ref050">50</xref>]; LDL [<xref ref-type="bibr" rid="pone.0217620.ref051">51</xref>–<xref ref-type="bibr" rid="pone.0217620.ref053">53</xref>]; Ischemic Stroke [<xref ref-type="bibr" rid="pone.0217620.ref054">54</xref>]; Hyperlipidemia [<xref ref-type="bibr" rid="pone.0217620.ref055">55</xref>]; oxLDL [<xref ref-type="bibr" rid="pone.0217620.ref006">6</xref>]; TC [<xref ref-type="bibr" rid="pone.0217620.ref052">52</xref>, <xref ref-type="bibr" rid="pone.0217620.ref053">53</xref>, <xref ref-type="bibr" rid="pone.0217620.ref056">56</xref>, <xref ref-type="bibr" rid="pone.0217620.ref057">57</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21225485</td>
<td align="left" colspan="1" rowspan="1">29</td>
<td align="left" colspan="1" rowspan="1">p.Arg4270Thr</td>
<td align="left" colspan="1" rowspan="1">rs1801702</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.0456</td>
<td align="left" colspan="1" rowspan="1">46,2,0</td>
<td align="left" colspan="1" rowspan="1">45,3,0</td>
<td align="left" colspan="1" rowspan="1">TC, LDL [<xref ref-type="bibr" rid="pone.0217620.ref058">58</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21225500</td>
<td align="left" colspan="1" rowspan="1">29</td>
<td align="left" colspan="1" rowspan="1">p.Val4265Ala</td>
<td align="left" colspan="1" rowspan="1">rs61743502</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.005139</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">Familial hypercholesterolemia [<xref ref-type="bibr" rid="pone.0217620.ref059">59</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21225753</td>
<td align="left" colspan="1" rowspan="1">29</td>
<td align="left" colspan="1" rowspan="1">p.Glu4181Lys</td>
<td align="left" colspan="1" rowspan="1">rs1042031</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.153</td>
<td align="left" colspan="1" rowspan="1">41,7,0</td>
<td align="left" colspan="1" rowspan="1">37,9,2</td>
<td align="left" colspan="1" rowspan="1">ADH [<xref ref-type="bibr" rid="pone.0217620.ref060">60</xref>]; Carotid plaques [<xref ref-type="bibr" rid="pone.0217620.ref061">61</xref>]; Hipertension, TG [<xref ref-type="bibr" rid="pone.0217620.ref062">62</xref>]; Serum lipid levels [<xref ref-type="bibr" rid="pone.0217620.ref063">63</xref>]; Familial hypercholesterolemia [<xref ref-type="bibr" rid="pone.0217620.ref064">64</xref>, <xref ref-type="bibr" rid="pone.0217620.ref065">65</xref>]; HDL [<xref ref-type="bibr" rid="pone.0217620.ref058">58</xref>]; HDL, LDL [<xref ref-type="bibr" rid="pone.0217620.ref066">66</xref>]; Breast Cancer [<xref ref-type="bibr" rid="pone.0217620.ref067">67</xref>]; Ischemic Stroke [<xref ref-type="bibr" rid="pone.0217620.ref068">68</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21225912</td>
<td align="left" colspan="1" rowspan="1">29</td>
<td align="left" colspan="1" rowspan="1">p.Val4128Met</td>
<td align="left" colspan="1" rowspan="1">rs1801703</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.006171</td>
<td align="left" colspan="1" rowspan="1">46,2,0</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">Exceptional longevity [<xref ref-type="bibr" rid="pone.0217620.ref069">69</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21228339</td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Ser3801Thr</td>
<td align="left" colspan="1" rowspan="1">rs12713540</td>
<td align="left" colspan="1" rowspan="1">T / P</td>
<td align="char" char="." colspan="1" rowspan="1">0.001046</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">PDR [<xref ref-type="bibr" rid="pone.0217620.ref070">70</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21228827</td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Arg3638Gln</td>
<td align="left" colspan="1" rowspan="1">rs1801701</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.06887</td>
<td align="left" colspan="1" rowspan="1">43,5,0</td>
<td align="left" colspan="1" rowspan="1">42,6,0</td>
<td align="left" colspan="1" rowspan="1">LDL [<xref ref-type="bibr" rid="pone.0217620.ref051">51</xref>]; TG [<xref ref-type="bibr" rid="pone.0217620.ref063">63</xref>]; CAD [<xref ref-type="bibr" rid="pone.0217620.ref071">71</xref>]; Familial hypercholesterolemia [<xref ref-type="bibr" rid="pone.0217620.ref064">64</xref>]; Ischemic Stroke [<xref ref-type="bibr" rid="pone.0217620.ref068">68</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21229446</td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Gln3432Glu</td>
<td align="left" colspan="1" rowspan="1">rs1042023</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.007588</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">LDL receptor binding [<xref ref-type="bibr" rid="pone.0217620.ref072">72</xref>, <xref ref-type="bibr" rid="pone.0217620.ref073">73</xref>]; Familial hypercholesterolemia [<xref ref-type="bibr" rid="pone.0217620.ref074">74</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21229609</td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Leu3377Leu</td>
<td align="left" colspan="1" rowspan="1">rs1799812</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1">0.006083</td>
<td align="left" colspan="1" rowspan="1">46,2,0</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">ADH [<xref ref-type="bibr" rid="pone.0217620.ref060">60</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21231524</td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Pro2739Leu</td>
<td align="left" colspan="1" rowspan="1">rs676210</td>
<td align="left" colspan="1" rowspan="1">D / D</td>
<td align="char" char="." colspan="1" rowspan="1">0.2928</td>
<td align="left" colspan="1" rowspan="1">17,24,7</td>
<td align="left" colspan="1" rowspan="1">41,6,1</td>
<td align="left" colspan="1" rowspan="1">MI [<xref ref-type="bibr" rid="pone.0217620.ref075">75</xref>]; oxLDL [<xref ref-type="bibr" rid="pone.0217620.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0217620.ref028">28</xref>]; TC [<xref ref-type="bibr" rid="pone.0217620.ref056">56</xref>]; Lipid metabolism phenotypes [<xref ref-type="bibr" rid="pone.0217620.ref076">76</xref>]; Familial hypercholesterolemia [<xref ref-type="bibr" rid="pone.0217620.ref064">64</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21231592</td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Ile2716Ile</td>
<td align="left" colspan="1" rowspan="1">rs6413458</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1">0.01952</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">45,3,0</td>
<td align="left" colspan="1" rowspan="1">Lp-PLA2 [<xref ref-type="bibr" rid="pone.0217620.ref077">77</xref>]; ADH [<xref ref-type="bibr" rid="pone.0217620.ref060">60</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21232125<xref ref-type="table-fn" rid="t002fn002">*</xref></td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Val2539Ile</td>
<td align="left" colspan="1" rowspan="1">rs148170480</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.002399</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21232128<xref ref-type="table-fn" rid="t002fn002">*</xref></td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Leu2538Leu</td>
<td align="left" colspan="1" rowspan="1">rs72653093</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1">0.001509</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">46,2,0</td>
<td align="left" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21232195</td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Thr2515Thr</td>
<td align="left" colspan="1" rowspan="1">rs693</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1">0.3899</td>
<td align="left" colspan="1" rowspan="1">17,24,7</td>
<td align="left" colspan="1" rowspan="1">7,22,19</td>
<td align="left" colspan="1" rowspan="1">Ischemic Stroke [<xref ref-type="bibr" rid="pone.0217620.ref054">54</xref>]; LDL [<xref ref-type="bibr" rid="pone.0217620.ref078">78</xref>–<xref ref-type="bibr" rid="pone.0217620.ref081">81</xref>]; Carotid plaques [<xref ref-type="bibr" rid="pone.0217620.ref061">61</xref>]; TC [<xref ref-type="bibr" rid="pone.0217620.ref079">79</xref>]; TG [<xref ref-type="bibr" rid="pone.0217620.ref080">80</xref>]; Breast Cancer [<xref ref-type="bibr" rid="pone.0217620.ref067">67</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21232341</td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Lys2467Ter</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">T / -</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21233877<xref ref-type="table-fn" rid="t002fn002">*</xref></td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Val1955Met</td>
<td align="left" colspan="1" rowspan="1">rs368970025</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.00008238</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21233972<xref ref-type="table-fn" rid="t002fn002">*</xref></td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.His1923Arg</td>
<td align="left" colspan="1" rowspan="1">rs533617</td>
<td align="left" colspan="1" rowspan="1">D / D</td>
<td align="char" char="." colspan="1" rowspan="1">0.03116</td>
<td align="left" colspan="1" rowspan="1">45,3,0</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">LDL, TC [<xref ref-type="bibr" rid="pone.0217620.ref082">82</xref>, <xref ref-type="bibr" rid="pone.0217620.ref083">83</xref>]; oxLDL [<xref ref-type="bibr" rid="pone.0217620.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0217620.ref028">28</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21234915</td>
<td align="left" colspan="1" rowspan="1">26</td>
<td align="left" colspan="1" rowspan="1">p.Leu1609Leu</td>
<td align="left" colspan="1" rowspan="1">rs72653083</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1">0.001726</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21236221</td>
<td align="left" colspan="1" rowspan="1">25</td>
<td align="left" colspan="1" rowspan="1">p.Pro1343Ser</td>
<td align="left" colspan="1" rowspan="1">rs374427541</td>
<td align="left" colspan="1" rowspan="1">D / D</td>
<td align="char" char="." colspan="1" rowspan="1">0.00003295</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">No</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21238367<xref ref-type="table-fn" rid="t002fn002">*</xref></td>
<td align="left" colspan="1" rowspan="1">22</td>
<td align="left" colspan="1" rowspan="1">p.Arg1128His</td>
<td align="left" colspan="1" rowspan="1">rs12713843</td>
<td align="left" colspan="1" rowspan="1">D / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.003708</td>
<td align="left" colspan="1" rowspan="1">47,0,1</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">LDL, TC [<xref ref-type="bibr" rid="pone.0217620.ref084">84</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21238413<xref ref-type="table-fn" rid="t002fn002">*</xref></td>
<td align="left" colspan="1" rowspan="1">22</td>
<td align="left" colspan="1" rowspan="1">p.Asp1113His</td>
<td align="left" colspan="1" rowspan="1">rs12713844</td>
<td align="left" colspan="1" rowspan="1">D / P</td>
<td align="char" char="." colspan="1" rowspan="1">0.006858</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">Spastic Paraplegia [<xref ref-type="bibr" rid="pone.0217620.ref085">85</xref>]; Familial hypercholesterolemia [<xref ref-type="bibr" rid="pone.0217620.ref086">86</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21245813<xref ref-type="table-fn" rid="t002fn002">*</xref></td>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1">p.Asn902Asn</td>
<td align="left" colspan="1" rowspan="1">rs1801700</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="char" char="." colspan="1" rowspan="1">0.03445</td>
<td align="left" colspan="1" rowspan="1">46,2,0</td>
<td align="left" colspan="1" rowspan="1">39,9,0</td>
<td align="left" colspan="1" rowspan="1">ADH [<xref ref-type="bibr" rid="pone.0217620.ref060">60</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21245889<xref ref-type="table-fn" rid="t002fn002">*</xref></td>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1">p.Pro877Leu</td>
<td align="left" colspan="1" rowspan="1">rs12714097</td>
<td align="left" colspan="1" rowspan="1">D / D</td>
<td align="char" char="." colspan="1" rowspan="1">0.000479</td>
<td align="left" colspan="1" rowspan="1">48,0,0</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">Familial hypercholesterolemia [<xref ref-type="bibr" rid="pone.0217620.ref087">87</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21249716</td>
<td align="left" colspan="1" rowspan="1">15</td>
<td align="left" colspan="1" rowspan="1">p.Val730Ile</td>
<td align="left" colspan="1" rowspan="1">rs12691202</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.02504</td>
<td align="left" colspan="1" rowspan="1">47,1,0</td>
<td align="left" colspan="1" rowspan="1">44,4,0</td>
<td align="left" colspan="1" rowspan="1">ADH [<xref ref-type="bibr" rid="pone.0217620.ref060">60</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21250914</td>
<td align="left" colspan="1" rowspan="1">14</td>
<td align="left" colspan="1" rowspan="1">p.Ala618Val</td>
<td align="left" colspan="1" rowspan="1">rs679899</td>
<td align="left" colspan="1" rowspan="1">T / D</td>
<td align="char" char="." colspan="1" rowspan="1">0.4857</td>
<td align="left" colspan="1" rowspan="1">19,16,13</td>
<td align="left" colspan="1" rowspan="1">30,15,3</td>
<td align="left" colspan="1" rowspan="1">FH [<xref ref-type="bibr" rid="pone.0217620.ref065">65</xref>]; MI [<xref ref-type="bibr" rid="pone.0217620.ref075">75</xref>]; LDL [<xref ref-type="bibr" rid="pone.0217620.ref051">51</xref>]; Hyperlipidemia [<xref ref-type="bibr" rid="pone.0217620.ref055">55</xref>]; Chronic kidney disease [<xref ref-type="bibr" rid="pone.0217620.ref088">88</xref>]; Coronary heart disease [<xref ref-type="bibr" rid="pone.0217620.ref089">89</xref>]; oxLDL [<xref ref-type="bibr" rid="pone.0217620.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0217620.ref028">28</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">21263900</td>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">p.Thr98Ile</td>
<td align="left" colspan="1" rowspan="1">rs1367117</td>
<td align="left" colspan="1" rowspan="1">T / B</td>
<td align="char" char="." colspan="1" rowspan="1">0.2619</td>
<td align="left" colspan="1" rowspan="1">29,14,5</td>
<td align="left" colspan="1" rowspan="1">18,24,6</td>
<td align="left" colspan="1" rowspan="1">LDL, TC [<xref ref-type="bibr" rid="pone.0217620.ref050">50</xref>, <xref ref-type="bibr" rid="pone.0217620.ref090">90</xref>]; Lipid metabolism phenotypes [<xref ref-type="bibr" rid="pone.0217620.ref076">76</xref>]</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001">
<p>SIFT score: T—Tolerated, D—Deleterious; PolyPhen-2 score: B—Benign, P—Possibly damaging, D—Probably damaging; ADH—autosomal dominant hypercholesterolemia, CAD—coronary artery disease, HDL—high density lipoprotein, LDL—low density lipoprotein, Lp-PLA2—lipoprotein-associated phospholipase A2, MI—myocardial infarction, oxLDL—oxidatively modified low density lipoprotein, PDR—proliferative diabetic retinopathy, TC—total cholesterol, TG—triglycerides.</p>
</fn>
<fn id="t002fn002">
<p>*SNPs significantly associated with oxLDL levels by BE-SKAT;</p>
</fn>
<fn id="t002fn003">
<p>**Number of patients with regarded variants genotypes presented as homozygous reference allele, heterozygous, homozygous alternative allele.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Eleven variants were present only in the L group. Six of them were rare NS variants: rs1801703 (p.Val4128Met), rs1042023 (p.Gln3432Glu), rs148170480 (p.Val2539Ile), rs368970025 (p.Val1955Met), rs374427541 (p.Pro1343Ser), rs12713843 (p.Arg1128His). Two NS variants unique for the L group were not singletons, they were found more than in one patient. Rare NS variant rs1801703 (p.Val4128Met) was found in two individuals, and the NS low-frequency SNP rs533617 (p.His1923Arg) was presented in three individuals. Moreover, two patients from the L group had synonymous change rs1799812 (p.Leu3377Leu) not presented in the H group.</p>
<p>Eight SNPs were unique to the H group. All NS variants out of them were rare singletons: five previously reported (p.Ser4392Asn, rs61743502 (p.Val4265Ala), rs12713540 (p.Ser3801Thr), rs12713844 (p.Asp1113His), rs12714097 (p.Pro877Leu)) and two novel variants (p.Lys4463Glu and p.Lys2467Ter). Also, two patients from the H group had synonymous change rs72653093 (p.Leu2538Leu) presented only in this group of patients.</p>
<p>For each variant out of 30 exonic variants obtained by the targeted sequencing, the MAF was received from the Exome Aggregation Consortium (ExAC) database (<ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>). There were two novel variants with no MAF data in our SNPs set. In order to account for these variants in the variant association testing, their MAF was defined as the minimal MAF observed in our SNPs set of 30 exonic variants.</p>
<p>Additionally, to exclude linked variants we performed linkage disequilibrium (LD) analysis based on 1000 Genomes Project data (<xref ref-type="supplementary-material" rid="pone.0217620.s005">S5 Fig</xref>). Two common variants rs676210 and rs1042034 in the considered SNPs set were in a perfect LD according to the public data; moreover, they were in a perfect LD according to our study. We excluded rs1042034 variant. The other four variants (rs6413458 and rs1801702, rs1799812 and rs1801703), which are in LD according to 1000 Genomes Project data, had the low MAF and were not linked in our study. We did not exclude any of these variants. Thus, we excluded only one variant rs1042034 and for the further variant association testing, we used 29 out of 30 exonic SNPs.</p>
</sec>
<sec id="sec013">
<title>Variant association testing</title>
<p>Initially, to find the association between the genetic variants and the oxLDL levels we used the WST [<xref ref-type="bibr" rid="pone.0217620.ref018">18</xref>], SKAT (with/without adjustment for covariates) [<xref ref-type="bibr" rid="pone.0217620.ref019">19</xref>] and optimal SKAT (SKAT-O) method which is based on combination of burden test and SKAT (with/without adjustment for covariates) [<xref ref-type="bibr" rid="pone.0217620.ref020">20</xref>]. As covariates we used age, sex, smoking status, body mass index, waist, HDL, CRP, lipoprotein (a), hypertension, myocardial infarction, diabetes mellitus, stroke and statins use.</p>
<p>First of all, we analyzed the rare SNPs out of 29 variants. We considered (i) the subgroup of variants defined as deleterious/damaging (DD) by the SIFT and PolyPhen-2 algorithms as the most plausible functional variants, (ii) the subgroup of NS variants, (iii) the entire group of rare variants (with synonymous and NS amino acid change). The same testing steps were conducted for the rare and low-frequency variants together. The results of the analysis are presented in <xref ref-type="table" rid="pone.0217620.t003">Table 3</xref>.</p>
<table-wrap id="pone.0217620.t003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0217620.t003</object-id>
<label>Table 3</label>
<caption>
<title>Association analysis between exonic <italic>APOB</italic> variants and oxLDL levels.</title>
</caption>
<alternatives>
<graphic id="pone.0217620.t003g" xlink:href="pone.0217620.t003"></graphic>
<table border="0" frame="box" rules="all">
<colgroup span="1">
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
<col align="left" span="1" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" style="border-bottom:thick"></th>
<th align="left" colspan="5" rowspan="1" style="border-bottom:thick">Rare variants (MAF&lt;0.01)</th>
<th align="left" colspan="5" rowspan="1" style="border-bottom:thick">Rare and low-frequency variants (MAF&lt;0.05)</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Test</th>
<th align="left" colspan="1" rowspan="1">WST</th>
<th align="left" colspan="1" rowspan="1">SKAT</th>
<th align="left" colspan="1" rowspan="1">SKAT with covariates</th>
<th align="left" colspan="1" rowspan="1">SKAT-O</th>
<th align="left" colspan="1" rowspan="1">SKAT-O with covariates</th>
<th align="left" colspan="1" rowspan="1">WST</th>
<th align="left" colspan="1" rowspan="1">SKAT</th>
<th align="left" colspan="1" rowspan="1">SKAT with covariates</th>
<th align="left" colspan="1" rowspan="1">SKAT-O</th>
<th align="left" colspan="1" rowspan="1">SKAT-O with covariates</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Deleterious/damaging<xref ref-type="table-fn" rid="t003fn001">*</xref></td>
<td align="char" char="." colspan="1" rowspan="1">0.244</td>
<td align="char" char="." colspan="1" rowspan="1">0.464</td>
<td align="char" char="." colspan="1" rowspan="1">0.358</td>
<td align="char" char="." colspan="1" rowspan="1">0.645</td>
<td align="char" char="." colspan="1" rowspan="1">0.443</td>
<td align="char" char="." colspan="1" rowspan="1">0.623</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.037</bold>
</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.004</bold>
</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.043</bold>
</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.006</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nonsynonymous</td>
<td align="char" char="." colspan="1" rowspan="1">0.829</td>
<td align="char" char="." colspan="1" rowspan="1">0.164</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.048</bold>
</td>
<td align="char" char="." colspan="1" rowspan="1">0.253</td>
<td align="char" char="." colspan="1" rowspan="1">0.089</td>
<td align="char" char="." colspan="1" rowspan="1">0.813</td>
<td align="char" char="." colspan="1" rowspan="1">0.164</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.034</bold>
</td>
<td align="char" char="." colspan="1" rowspan="1">0.278</td>
<td align="char" char="." colspan="1" rowspan="1">0.065</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Synonymous &amp; nonsynonymous</td>
<td align="char" char="." colspan="1" rowspan="1">0.789</td>
<td align="char" char="." colspan="1" rowspan="1">0.087</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.034</bold>
</td>
<td align="char" char="." colspan="1" rowspan="1">0.126</td>
<td align="char" char="." colspan="1" rowspan="1">0.064</td>
<td align="char" char="." colspan="1" rowspan="1">0.173</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.017</bold>
</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.003</bold>
</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.034</bold>
</td>
<td align="char" char="." colspan="1" rowspan="1">
<bold>0.006</bold>
</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001">
<p>*By SIFT and PolyPhen-2 algorithms.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>As follows from <xref ref-type="table" rid="pone.0217620.t003">Table 3</xref>, the WST did not overcome the required level of significance in none of the groups, which could be due to the large number of multidirectional and neutral variants. However, the SKAT-O adjusted for covariates did not overcome the level of significance in the group of rare variants as well. The SKAT-O analysis showed that the best combination of the burden test and SKAT method was the SKAT test itself. The behavior of SKAT-O depending on the combination coefficient is shown on <xref ref-type="supplementary-material" rid="pone.0217620.s006">S6 Fig</xref>. Thus, in the following analysis, we used only the SKAT, because the corresponding <italic>P</italic>-value was calculated more accurately. As it can be seen in <xref ref-type="table" rid="pone.0217620.t003">Table 3</xref>, the addition of covariates decreased the <italic>P</italic>-value.</p>
<p>Testing with the SKAT adjusted for the covariates showed no association between the rare DD variants and the oxLDL levels (<italic>P</italic> = 0.358). The <italic>P</italic>-value of the former with addition of the low-frequency DD variant rs533617 (p.His1923Arg) decreased to <italic>P</italic> = 0.004. The functional prediction algorithms could fail the correct identification of the any NS sequence variations, as it was shown for the SNPs associated with the LDL and the dominant hypercholesterolemia [<xref ref-type="bibr" rid="pone.0217620.ref091">91</xref>]. Therefore, the consideration of other variants seemed reasonable.</p>
<p>The NS variants that alter an amino acid can change the protein function [<xref ref-type="bibr" rid="pone.0217620.ref038">38</xref>], thus such variants are more likely to affect the phenotype compared to the synonymous variants. However, even if the SNP does not change amino acid, it can still affect the gene function by altering the mRNA stability or splicing [<xref ref-type="bibr" rid="pone.0217620.ref092">92</xref>, <xref ref-type="bibr" rid="pone.0217620.ref093">93</xref>]. The analysis of the NS variants subgroup and of the subgroup with the synonymous and the NS variants showed a significant association with the oxLDL levels according to SKAT adjusted for covariates. The <italic>P</italic>-value was the least in the subgroup with the synonymous and the NS variants. This indicates that both NS SNPs and synonymous contribute to the oxLDL levels. Additionally, the <italic>P</italic>-value decreased in all subgroups of the rare variants after adding the variants with the higher MAF—low-frequency variants.</p>
<p>Then, we conducted the joint analysis of all 29 variants which included rare, low-frequency and common variants. For this purpose, we used the SKAT-C method which showed the significant association of all 29 SNPs with oxLDL levels (<italic>P</italic> = 2.7 × 10<sup>−8</sup>). However, some of these variants could be neutral, so they should be excluded from the analysis. Methods for finding the causal variants differ depending on variants frequency. Therefore, we divided the SNPs set of 29 variants into two subgroups: rare with low-frequency variants and common variants. The scheme of the joint testing of these SNPs is shown on the <xref ref-type="fig" rid="pone.0217620.g003">Fig 3</xref>.</p>
<fig id="pone.0217620.g003" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0217620.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Joint analysis of rare, low-frequency and common exonic variants obtained by targeted sequencing.</title>
</caption>
<graphic xlink:href="pone.0217620.g003"></graphic>
</fig>
<p>For the subgroup of rare and low-frequency variants we applied the ADA [<xref ref-type="bibr" rid="pone.0217620.ref024">24</xref>] and BE-SKAT [<xref ref-type="bibr" rid="pone.0217620.ref021">21</xref>] tests. ADA test chose the variant rs533617 (p.His1923Arg) with the <italic>P</italic> = 0.3. We used ADA implementation based on the Fisher’s test. We presume that the small size of patients group caused the high <italic>P</italic>-values in the univariate analysis by the Fisher’s test, so this could cause the failure of the ADA test. As noted in [<xref ref-type="bibr" rid="pone.0217620.ref023">23</xref>], the BE-SKAT is less conservative than the ADA test, i.e. this method can select more variants. However, the BE-SKAT can leave more neutral variants than ADA. The BE-SKAT selected 9 variants: p.Gln4480Gln, rs148170480 (p.Val2539Ile), rs72653093 (p.Leu2538Leu), rs368970025 (p.Val1955Met), rs533617 (p.His1923Arg), rs12713843 (p.Arg1128His), rs12713844 (p.Asp1113His), rs1801700 (p.Asn902Asn), rs12714097 (p.Pro877Leu). The initial <italic>P</italic>-value of the SKAT was reduced from 0.003 in 23 variants group to 6.8 × 10<sup>−5</sup> in 9 variants group.</p>
<p>For the subgroup of common variants, we applied an elastic net with cross-validation based on the AUC-ROC metric [<xref ref-type="bibr" rid="pone.0217620.ref044">44</xref>]. According to the present analysis, all considered common variants were used in the model. Thereby, we included all 6 common variants in further analysis.</p>
<p>Finally, we combined the analysis results of both subgroups (rare and low-frequency variants and common variants) and revealed a set of 15 variants for which the SKAT-C method rejected the null hypothesis of the absence of association at a required significance level (<italic>P</italic> = 1.8 × 10<sup>−8</sup>). Thus, as the result of our statistical analysis, predominantly neutral variants were excluded from the analysis, reducing the number of variants and the <italic>P</italic>-value.</p>
<p>Six common variants included in the set of 15 SNPs, associated with oxLDL levels by the SKAT-C, previously were associated with the LDL, TG and other lipid parameters and different cardiovascular events (see <xref ref-type="table" rid="pone.0217620.t002">Table 2</xref>). They may affect the oxLDL levels but significant associations were confirmed in the GWAS separately only for the rs676210 variant.</p>
<p>Rare and low-frequency variants were more interesting in the context of finding the ‘missing heritability’ and explaining the variation in oxLDL levels. The SNP rs533617 (p.His1923Arg) was a potentially causal variant by the statistical analysis. It was presented only in three individuals from the L group and was predicted to be the DD. However, this variant was observed only in patients with the SNP rs676210 significantly associated with the oxLDL by GWAS. For this reason, we could neither confirm nor entirely exclude the contribution of variant rs533617 to the decreased oxLDL levels.</p>
<p>The synonymous variant rs72653093 (p.Leu2538Leu) was presented in two individuals from the H group. It was included in the SNPs set obtained by BE-SKAT and was not published previously. The other non singleton variants rs1801703 (p.Val4128Met) and rs1799812 (p.Leu3377Leu), found only in the L group, were excluded by the BE-SKAT as neutral variants. This could be due to the covariates adjustment or due to the small sample size.</p>
<p>The single patient in the L group was homozygous for variant rs12713843 (p.Arg1128His). This SNP was predicted to be deleterious by the SIFT but benign by PolyPhen-2. This difference may be due to the difference in mathematical algorithms underlying methods. Since SIFT and PolyPhen-2 algorithms do not provide the evidence that this SNP might be the deleterious one for sure, their predictions should be interpreted with caution. Previously the variant rs12713843 was associated with lower LDL and lower TC levels [<xref ref-type="bibr" rid="pone.0217620.ref084">84</xref>]. The carrier of this SNP had lower levels of these parameters in comparison to the median value in the L group (TC = 3.76 mmol/l, LDL = 1.29 mmol/l, both lower than the 25th percentile) and the minimal oxLDL level among the entire cohort (oxLDL = 21.03 U/dl). Thus, the rs12713843 variant may be causative variant for decreasing oxLDL level. However, this decrease may not be caused by the oxidation, but it is due to the reduced LDL and TC levels, described in [<xref ref-type="bibr" rid="pone.0217620.ref084">84</xref>]. Additionally, the carrier of this SNP had the other variant rs676210, associated with the decreased oxLDL level.</p>
<p>NS singletons rs12713844 (p.Asp1113His) and rs12714097 (p.Pro877Leu) presented in the H group were selected by the BE-SKAT. Both were predicted to be deleterious and both previously reported with respect to the familial hypercholesterolemia (<xref ref-type="table" rid="pone.0217620.t002">Table 2</xref>). Novel variants p.Lys4463Glu and p.Lys2467Ter, presented only in the H group, were excluded by the BE-SKAT as being neutral.</p>
</sec>
<sec id="sec014">
<title><italic>APOB</italic> gene evolutionary conservation analysis</title>
<p>To examine the relationship between the evolutionary conservation and functional effects of the NS sequence variations, identified by targeted sequencing, we aligned the human ApoB amino acid sequence with the sequences from 11 other species (<xref ref-type="fig" rid="pone.0217620.g004">Fig 4</xref>).</p>
<fig id="pone.0217620.g004" orientation="portrait" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0217620.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Evolutionary sequence conservation and predicted functional effects of nonsynonymous sequence variations in <italic>APOB</italic>.</title>
<p>Conservation for each variation found in the low oxLDL subjects only (top), the both low and high oxLDL subjects (middle), or high oxLDL levels group (bottom). An asterisk (*) indicates the SNPs significantly associated with oxLDL levels by the BE-SKAT. The alignment includes <italic>Homo sapiens</italic> (human), <italic>Pan troglodytes</italic> (chimpanzee), <italic>Macaca mulatta</italic> (Rhesus monkey), <italic>Oryctolagus cuniculus</italic> (rabbit), <italic>Bos taurus</italic> (cow), <italic>Canis lupus familiaris</italic> (dog), <italic>Echinops telfairi</italic> (hedgehog), <italic>Mus musculus</italic> (house mouse), <italic>Rattus norvegicus</italic> (rat), <italic>Gallus gallus</italic> (chicken), <italic>Xenopus tropicalis</italic> (frog), <italic>Danio rerio</italic> (zebrafish). The predicted effect of each variant on protein function is indicated (right columns). SIFT: T—tolerated; D—deleterious. PolyPhen-2: B—benign; P—possibly damaging; D—probably damaging.</p>
</caption>
<graphic xlink:href="pone.0217620.g004"></graphic>
</fig>
<p>Two SNPs rs533617 (p.His1923Arg) and rs374427541 (p.Pro1343Ser) in the L group were highly conserved from human to zebrafish and one (rs12713843 (p.Arg1128His)) to frog. There were three substituted amino acids conserved in primates and some other mammals: rs1801695 (p.Ala4481Thr), rs1042023 (p.Gln3432Glu), rs148170480 (p.Val2539Ile).</p>
<p>In the H group two changed amino acid residues rs12713540 (p.Ser3801Thr) and rs12713844 (p.Asp1113His) were completely conserved from primates to rats, and rs12714097 (p.Pro877Leu) was conserved from human to zebrafish, except cow.</p>
<p>Both groups included three common variants highly conserved from human to zebrafish: rs676210 (p.Pro2739Leu), rs12691202 (p.Val730Ile) and rs679899 (p.Ala618Val).</p>
<p>It was initially assumed that highly conserved NS variation at amino acid residues would be found only in either L or H group, as demonstrated previously for the genetic variation in <italic>NPC1L1</italic> [<xref ref-type="bibr" rid="pone.0217620.ref015">15</xref>]. However, we found several variants common to both extremes. Also, it was shown previously for the variants of <italic>PCSK9</italic> [<xref ref-type="bibr" rid="pone.0217620.ref091">91</xref>] and <italic>APOB</italic> [<xref ref-type="bibr" rid="pone.0217620.ref051">51</xref>].</p>
<p>It is also interesting that two SNPs from the L group were highly conserved in all regarded species and had the DD status. While we suggested that the low oxLDL level is a healthier trait in comparison with the increased oxLDL, high evolutionary sequence conservation suggests that the variants, responsible for the lowering of the oxLDL levels, also cause the loss of any other important functions. Thus, the positive effect of variants which decrease oxLDL level and deleterious effect revealed by <italic>in silico</italic> prediction methods remain controversial.</p>
</sec>
</sec>
<sec id="sec015" sec-type="conclusions">
<title>Conclusion</title>
<p>The major finding of this study is association of the oxLDL levels with both common and rare variants of the <italic>APOB</italic> gene. For the first time, we showed the association of the rare variants with the circulating oxLDL levels. Additionally, we performed the joint analysis of rare, low-frequency and common <italic>APOB</italic> variants. Whereas the group of variants associated with oxLDL levels was revealed, the rare or novel variants still should be interpreted cautiously. It is necessary to evaluate the variant and the gene in the context of the patient’s and family’s history, physical examinations, and previous laboratory tests to distinguish between variants that cause the patient’s disorder and those that are benign. Functional evaluation can also provide a more definitive assessment of the variant pathogenicity.</p>
<p><italic>APOB</italic> gene variants can change secondary structure of the human ApoB and the LDL particle size in comparison with the wild type LDL particle [<xref ref-type="bibr" rid="pone.0217620.ref094">94</xref>]. These changes may also impact the LDL oxidation. To determine the molecular biological effects of the genetic variant as well as the interactions with other variants and to understand the mechanisms of oxidation, mathematical modeling and high-throughput technologies such as mass spectrometry or infrared spectroscopy analysis could be applied. Such studies of <italic>APOB</italic> variants may provide useful information to understand their role in the LDL oxidation and atherosclerosis progression.</p>
</sec>
<sec id="sec016" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material content-type="local-data" id="pone.0217620.s001">
<label>S1 Fig</label>
<caption>
<title>Binding specificity of native low density lipoprotein (nLDL), malondialdehyde-modified LDL (MDA-LDL), glyoxal-modified LDL (G-LDL) and methylglyoxal-modified LDL (MG-LDL) to the mAb-4E6 antibody.</title>
<p>(TIF)</p>
</caption>
<media xlink:href="pone.0217620.s001.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0217620.s002">
<label>S2 Fig</label>
<caption>
<title>Principal component analysis (PCA) for GWAS samples.</title>
<p>A. The colors ranged from red (high oxLDL levels) to blue (low oxLDL levels). The matching suggested minimal evidence of population stratification. B. The colors indicate 48 individuals with the highest oxLDL levels (red) and 48 individuals with the lowest oxLDL levels (blue).</p>
<p>(TIFF)</p>
</caption>
<media xlink:href="pone.0217620.s002.tiff">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0217620.s003">
<label>S3 Fig</label>
<caption>
<title>Quantile-quantile plot of the observed and expected <italic>P</italic>-values obtained from GWAS with oxLDL levels showing a clear deviation from normal distribution.</title>
<p>(TIF)</p>
</caption>
<media xlink:href="pone.0217620.s003.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0217620.s004">
<label>S4 Fig</label>
<caption>
<title>Regional plot of the <italic>APOB</italic> region with SNPs significantly associated with oxLDL levels.</title>
<p>Dots show <italic>P</italic>-values from GWAS on the −<italic>log</italic>10 scale (vertical axis), and the chromosomal position (horizontal axis). Pairwise linkage disequilibrium (<italic>r</italic><sup>2</sup>) from the most significant SNP (rs11902417) is color-coded. The light blue curve shows the local recombination rate based on 1000 Genomes EUR data (release Nov 24, 2014).</p>
<p>(TIF)</p>
</caption>
<media xlink:href="pone.0217620.s004.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0217620.s005">
<label>S5 Fig</label>
<caption>
<title>Heatmap of pairwise linkage disequilibrium (LD) statistics for <italic>APOB</italic> gene exonic variants.</title>
<p>The colors of the cells refer to r<sup>2</sup> values and show the amount of LD between two markers. LD statistics between a pair of SNPs was calculated using haplotype CEU data from the 1000 Genomes Project.</p>
<p>(TIF)</p>
</caption>
<media xlink:href="pone.0217620.s005.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0217620.s006">
<label>S6 Fig</label>
<caption>
<title>P-value of SKAT-O with covariates on synonymous and nonsynonymous variants.</title>
<p>The plot illustrates the behavior of SKAT-O and its dependence on the combination coefficient of SKAT and Burden test. If the coefficient is equal to null, SKAT-O behaves as SKAT. If the coefficient is equal to one, SKAT-O behaves as Burden test.</p>
<p>(TIF)</p>
</caption>
<media xlink:href="pone.0217620.s006.tif">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0217620.s007">
<label>S1 Dataset</label>
<caption>
<title>Capture design coordinates for targeted sequencing.</title>
<p>TargetSeq Custom Enrichment Kit was designed to target the region containing the complete genomic sequence of the <italic>APOB</italic> gene in locus 2p24-p23 (chr2: 20996301-21494945; GRCh37/hg19 reference human genome).</p>
<p>(DOC)</p>
</caption>
<media xlink:href="pone.0217620.s007.doc">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0217620.s008">
<label>S1 Appendix</label>
<caption>
<title>Materials and methods for more details.</title>
<p>(PDF)</p>
</caption>
<media xlink:href="pone.0217620.s008.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0217620.s009">
<label>S1 Table</label>
<caption>
<title>Correlation of oxLDL levels with biochemical parameters and ultrasound markers of atherosclerosis.</title>
<p>(PDF)</p>
</caption>
<media xlink:href="pone.0217620.s009.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
<supplementary-material content-type="local-data" id="pone.0217620.s010">
<label>S2 Table</label>
<caption>
<title>Fourteen the most significant SNPs obtained by GWAS for oxLDL levels in 725 samples.</title>
<p>All SNPs are localized on Chromosome 2 in <italic>APOB</italic> gene region.</p>
<p>(PDF)</p>
</caption>
<media xlink:href="pone.0217620.s010.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank the participants for taking part in the study. The authors acknowledge the contributions of I. Zhanin for the help with targeted sequencing, E. Khrameeva for the help with genotyping and for her advice concerning the use of the PLINK, and S. Smetnev for the technical expertise.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0217620.ref001">
<label>1</label>
<mixed-citation publication-type="journal">
<name><surname>Di Pietro</surname><given-names>N</given-names></name>, <name><surname>Formoso</surname><given-names>G</given-names></name>, <name><surname>Pandolfi</surname><given-names>A</given-names></name>. <article-title>Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis</article-title>. <source/>Vascul Pharmacol. <year>2016</year>;<volume>84</volume>:<fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.vph.2016.05.013</pub-id>
<pub-id pub-id-type="pmid">27256928</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref002">
<label>2</label>
<mixed-citation publication-type="journal">
<name><surname>Linton</surname><given-names>MF</given-names></name>, <name><surname>Yancey</surname><given-names>PG</given-names></name>, <name><surname>Davies</surname><given-names>SS</given-names></name>, <name><surname>Jerome</surname><given-names>WGJ</given-names></name>, <name><surname>Linton</surname><given-names>EF</given-names></name>, <name><surname>Vickers</surname><given-names>KC</given-names></name>. <source/>The role of lipids and lipoproteins in atherosclerosis. <year>2015</year>;.</mixed-citation>
</ref>
<ref id="pone.0217620.ref003">
<label>3</label>
<mixed-citation publication-type="journal">
<name><surname>Lankin</surname><given-names>VZ</given-names></name>, <name><surname>Tikhaze</surname><given-names>AK</given-names></name>, <name><surname>Kukharchuk</surname><given-names>VV</given-names></name>, <name><surname>Konovalova</surname><given-names>GG</given-names></name>, <name><surname>Pisarenko</surname><given-names>OI</given-names></name>, <name><surname>Kaminnyi</surname><given-names>AI</given-names></name>, <etal>et al</etal>
<article-title>Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins</article-title>. <source/>Mol Cell Biochem. <year>2003</year>;<volume>249</volume>(<issue>1–2</issue>):<fpage>129</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1023/A:1024742907379</pub-id>
<pub-id pub-id-type="pmid">12956408</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref004">
<label>4</label>
<mixed-citation publication-type="journal">
<name><surname>Lankin</surname><given-names>VZ</given-names></name>, <name><surname>Tikhaze</surname><given-names>AK</given-names></name>. <article-title>Role of oxidative stress in the genesis of atherosclerosis and diabetes mellitus: a personal look back on 50 years of research</article-title>. <source/>Curr Aging Sci. <year>2017</year>;<volume>10</volume>(<issue>1</issue>):<fpage>18</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.2174/1874609809666160926142640</pub-id>
<pub-id pub-id-type="pmid">27677837</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref005">
<label>5</label>
<mixed-citation publication-type="journal">
<name><surname>Lankin</surname><given-names>VZ</given-names></name>, <name><surname>Tikhaze</surname><given-names>AK</given-names></name>, <name><surname>Kumskova</surname><given-names>EM</given-names></name>. <article-title>Macrophages actively accumulate malonyldialdehyde-modified but not enzymatically oxidized low density lipoprotein</article-title>. <source/>Mol Cell Biochem. <year>2012</year>;<volume>365</volume>(<issue>1-2</issue>):<fpage>93</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-012-1247-5</pub-id>
<pub-id pub-id-type="pmid">22307746</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref006">
<label>6</label>
<mixed-citation publication-type="journal">
<name><surname>Mäkelä</surname><given-names>KM</given-names></name>, <name><surname>Seppälä</surname><given-names>I</given-names></name>, <name><surname>Hernesniemi</surname><given-names>JA</given-names></name>, <name><surname>Lyytikäinen</surname><given-names>LP</given-names></name>, <name><surname>Oksala</surname><given-names>N</given-names></name>, <name><surname>Kleber</surname><given-names>ME</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide association study pinpoints a new functional apolipoprotein B variant influencing oxidized low-density lipoprotein levels but not cardiovascular events: AtheroRemo Consortium</article-title>. <source/>Circ Cardiovasc Genet. <year>2013</year>;<volume>6</volume>(<issue>1</issue>):<fpage>73</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.112.964965</pub-id>
<pub-id pub-id-type="pmid">23247145</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref007">
<label>7</label>
<mixed-citation publication-type="journal">
<name><surname>Zuk</surname><given-names>O</given-names></name>, <name><surname>Hechter</surname><given-names>E</given-names></name>, <name><surname>Sunyaev</surname><given-names>SR</given-names></name>, <name><surname>Lander</surname><given-names>ES</given-names></name>. <article-title>The mystery of missing heritability: Genetic interactions create phantom heritability</article-title>. <source/>Proc Natl Acad Sci USA. <year>2012</year>;<volume>109</volume>(<issue>4</issue>):<fpage>1193</fpage>–<lpage>1198</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1119675109</pub-id>
<pub-id pub-id-type="pmid">22223662</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref008">
<label>8</label>
<mixed-citation publication-type="journal">
<name><surname>Schork</surname><given-names>NJ</given-names></name>, <name><surname>Murray</surname><given-names>SS</given-names></name>, <name><surname>Frazer</surname><given-names>KA</given-names></name>, <name><surname>Topol</surname><given-names>EJ</given-names></name>. <article-title>Common vs. rare allele hypotheses for complex diseases</article-title>. <source/>Curr Opin Genet Dev. <year>2009</year>;<volume>19</volume>(<issue>3</issue>):<fpage>212</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2009.04.010</pub-id>
<pub-id pub-id-type="pmid">19481926</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref009">
<label>9</label>
<mixed-citation publication-type="journal">
<name><surname>Bomba</surname><given-names>L</given-names></name>, <name><surname>Walter</surname><given-names>K</given-names></name>, <name><surname>Soranzo</surname><given-names>N</given-names></name>. <article-title>The impact of rare and low-frequency genetic variants in common disease</article-title>. <source/>Genome biol. <year>2017</year>;<volume>18</volume>(<issue>1</issue>):<fpage>77</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-017-1212-4</pub-id>
<pub-id pub-id-type="pmid">28449691</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref010">
<label>10</label>
<mixed-citation publication-type="journal">
<name><surname>Lusis</surname><given-names>AJ</given-names></name>. <article-title>Genetics of atherosclerosis</article-title>. <source/>Trends Genet. <year>2012</year>;<volume>28</volume>(<issue>6</issue>):<fpage>267</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2012.03.001</pub-id>
<pub-id pub-id-type="pmid">22480919</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref011">
<label>11</label>
<mixed-citation publication-type="journal">
<name><surname>Peloso</surname><given-names>GM</given-names></name>, <name><surname>Auer</surname><given-names>PL</given-names></name>, <name><surname>Bis</surname><given-names>JC</given-names></name>, <name><surname>Voorman</surname><given-names>A</given-names></name>, <name><surname>Morrison</surname><given-names>AC</given-names></name>, <name><surname>Stitziel</surname><given-names>NO</given-names></name>, <etal>et al</etal>
<article-title>Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks</article-title>. <source/>Am J Hum Genet. <year>2014</year>;<volume>94</volume>(<issue>2</issue>):<fpage>223</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2014.01.009</pub-id>
<pub-id pub-id-type="pmid">24507774</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref012">
<label>12</label>
<mixed-citation publication-type="journal">
<name><surname>Cohen</surname><given-names>JC</given-names></name>, <name><surname>Kiss</surname><given-names>RS</given-names></name>, <name><surname>Pertsemlidis</surname><given-names>A</given-names></name>, <name><surname>Marcel</surname><given-names>YL</given-names></name>, <name><surname>McPherson</surname><given-names>R</given-names></name>, <name><surname>Hobbs</surname><given-names>HH</given-names></name>. <article-title>Multiple rare alleles contribute to low plasma levels of HDL cholesterol</article-title>. <source/>Science. <year>2004</year>;<volume>305</volume>(<issue>5685</issue>):<fpage>869</fpage>–<lpage>872</lpage>. <pub-id pub-id-type="doi">10.1126/science.1099870</pub-id>
<pub-id pub-id-type="pmid">15297675</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref013">
<label>13</label>
<mixed-citation publication-type="journal">
<name><surname>Brown</surname><given-names>MS</given-names></name>, <name><surname>Goldstein</surname><given-names>JL</given-names></name>. <article-title>A receptor-mediated pathway for cholesterol homeostasis</article-title>. <source/>Science. <year>1986</year>;<volume>232</volume>(<issue>4746</issue>):<fpage>34</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1126/science.3513311</pub-id>
<pub-id pub-id-type="pmid">3513311</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref014">
<label>14</label>
<mixed-citation publication-type="journal">
<name><surname>Cohen</surname><given-names>J</given-names></name>, <name><surname>Pertsemlidis</surname><given-names>A</given-names></name>, <name><surname>Kotowski</surname><given-names>IK</given-names></name>, <name><surname>Graham</surname><given-names>R</given-names></name>, <name><surname>Garcia</surname><given-names>CK</given-names></name>, <name><surname>Hobbs</surname><given-names>HH</given-names></name>. <article-title>Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9</article-title>. <source/>Nat Genet. <year>2005</year>;<volume>37</volume>(<issue>2</issue>):<fpage>161</fpage>–<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1038/ng1509</pub-id>
<pub-id pub-id-type="pmid">15654334</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref015">
<label>15</label>
<mixed-citation publication-type="journal">
<name><surname>Cohen</surname><given-names>JC</given-names></name>, <name><surname>Pertsemlidis</surname><given-names>A</given-names></name>, <name><surname>Fahmi</surname><given-names>S</given-names></name>, <name><surname>Esmail</surname><given-names>S</given-names></name>, <name><surname>Vega</surname><given-names>GL</given-names></name>, <name><surname>Grundy</surname><given-names>SM</given-names></name>, <etal>et al</etal>
<article-title>Multiple rare variants in <italic>NPC1L1</italic> associated with reduced sterol absorption and plasma low-density lipoprotein levels</article-title>. <source/>Proc Natl Acad Sci USA. <year>2006</year>;<volume>103</volume>(<issue>6</issue>):<fpage>1810</fpage>–<lpage>1815</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0508483103</pub-id>
<pub-id pub-id-type="pmid">16449388</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref016">
<label>16</label>
<mixed-citation publication-type="journal">
<name><surname>Burnett</surname><given-names>JR</given-names></name>, <name><surname>Hooper</surname><given-names>AJ</given-names></name>. <article-title>Common and rare gene variants affecting plasma LDL cholesterol</article-title>. <source/>Clin Biochem Rev. <year>2008</year>;<volume>29</volume>(<issue>1</issue>):<fpage>11</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="pmid">18566665</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref017">
<label>17</label>
<mixed-citation publication-type="journal">
<name><surname>Rytova</surname><given-names>AI</given-names></name>, <name><surname>Khlebus</surname><given-names>EY</given-names></name>, <name><surname>Shevtsov</surname><given-names>AE</given-names></name>, <name><surname>Kutsenko</surname><given-names>VA</given-names></name>, <name><surname>Shcherbakova</surname><given-names>NV</given-names></name>, <name><surname>Zharikova</surname><given-names>AA</given-names></name>, <etal>et al</etal>
<article-title>Modern probabilistic and statistical approaches to search for nucleotide sequence options associated with integrated diseases</article-title>. <source/>Russ J Genet. <year>2017</year>;<volume>53</volume>(<issue>10</issue>):<fpage>1091</fpage>–<lpage>1104</lpage>. <pub-id pub-id-type="doi">10.1134/S1022795417100088</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref018">
<label>18</label>
<mixed-citation publication-type="journal">
<name><surname>Madsen</surname><given-names>BE</given-names></name>, <name><surname>Browning</surname><given-names>SR</given-names></name>. <article-title>A groupwise association test for rare mutations using a weighted sum statistic</article-title>. <source/>PLoS Genet. <year>2009</year>;<volume>5</volume>(<issue>2</issue>):<fpage>e1000384</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000384</pub-id>
<pub-id pub-id-type="pmid">19214210</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref019">
<label>19</label>
<mixed-citation publication-type="journal">
<name><surname>Wu</surname><given-names>MC</given-names></name>, <name><surname>Lee</surname><given-names>S</given-names></name>, <name><surname>Cai</surname><given-names>T</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Boehnke</surname><given-names>M</given-names></name>, <name><surname>Lin</surname><given-names>X</given-names></name>. <article-title>Rare-variant association testing for sequencing data with the sequence kernel association test</article-title>. <source/>Am J Hum Genet. <year>2011</year>;<volume>89</volume>(<issue>1</issue>):<fpage>82</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2011.05.029</pub-id>
<pub-id pub-id-type="pmid">21737059</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref020">
<label>20</label>
<mixed-citation publication-type="journal">
<name><surname>Lee</surname><given-names>S</given-names></name>, <name><surname>Emond</surname><given-names>MJ</given-names></name>, <name><surname>Bamshad</surname><given-names>MJ</given-names></name>, <name><surname>Barnes</surname><given-names>KC</given-names></name>, <name><surname>Rieder</surname><given-names>MJ</given-names></name>, <name><surname>Nickerson</surname><given-names>DA</given-names></name>, <etal>et al</etal>
<article-title>Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies</article-title>. <source/>Am J Hum Genet. <year>2012</year>;<volume>91</volume>(<issue>2</issue>):<fpage>224</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.06.007</pub-id>
<pub-id pub-id-type="pmid">22863193</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref021">
<label>21</label>
<mixed-citation publication-type="journal">
<name><surname>Ionita-Laza</surname><given-names>I</given-names></name>, <name><surname>Lee</surname><given-names>S</given-names></name>, <name><surname>Makarov</surname><given-names>V</given-names></name>, <name><surname>Buxbaum</surname><given-names>JD</given-names></name>, <name><surname>Lin</surname><given-names>X</given-names></name>. <article-title>Sequence kernel association tests for the combined effect of rare and common variants</article-title>. <source/>Am J Hum Genet. <year>2013</year>;<volume>92</volume>(<issue>6</issue>):<fpage>841</fpage>–<lpage>853</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.04.015</pub-id>
<pub-id pub-id-type="pmid">23684009</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref022">
<label>22</label>
<mixed-citation publication-type="journal">
<name><surname>Ionita-Laza</surname><given-names>I</given-names></name>, <name><surname>Capanu</surname><given-names>M</given-names></name>, <name><surname>De Rubeis</surname><given-names>S</given-names></name>, <name><surname>McCallum</surname><given-names>K</given-names></name>, <name><surname>Buxbaum</surname><given-names>JD</given-names></name>. <article-title>Identification of rare causal variants in sequence-based studies: methods and applications to VPS13B, a gene involved in Cohen syndrome and autism</article-title>. <source/>PLoS Genet. <year>2014</year>;<volume>10</volume>(<issue>12</issue>):<fpage>e1004729</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1004729</pub-id>
<pub-id pub-id-type="pmid">25502226</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref023">
<label>23</label>
<mixed-citation publication-type="journal">
<name><surname>Lin</surname><given-names>WY</given-names></name>. <article-title>Beyond rare-variant association testing: pinpointing rare causal variants in case-control sequencing study</article-title>. <source/>Sci Rep. <year>2016</year>;<volume>6</volume>:<fpage>21824</fpage>
<pub-id pub-id-type="doi">10.1038/srep21824</pub-id>
<pub-id pub-id-type="pmid">26903168</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref024">
<label>24</label>
<mixed-citation publication-type="journal">
<name><surname>Yu</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Bergen</surname><given-names>AW</given-names></name>, <name><surname>Pfeiffer</surname><given-names>RM</given-names></name>, <name><surname>Rosenberg</surname><given-names>PS</given-names></name>, <name><surname>Caporaso</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Pathway analysis by adaptive combination of P-values</article-title>. <source/>Genet Epidemiol. <year>2009</year>;<volume>33</volume>(<issue>8</issue>):<fpage>700</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1002/gepi.20422</pub-id>
<pub-id pub-id-type="pmid">19333968</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref025">
<label>25</label>
<mixed-citation publication-type="journal">
<name><surname>Conroy</surname><given-names>RM</given-names></name>, <name><surname>Pyörälä</surname><given-names>K</given-names></name>, <name><surname>Fitzgerald</surname><given-names>AP</given-names></name>, <name><surname>Sans</surname><given-names>S</given-names></name>, <name><surname>Menotti</surname><given-names>A</given-names></name>, <name><surname>De Backer</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project</article-title>. <source/>Eur Heart J. <year>2003</year>;<volume>24</volume>(<issue>11</issue>):<fpage>987</fpage>–<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1016/s0195-668x(03)00114-3</pub-id>
<pub-id pub-id-type="pmid">12788299</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref026">
<label>26</label>
<mixed-citation publication-type="journal">
<name><surname>Lankin</surname><given-names>V</given-names></name>, <name><surname>Konovalova</surname><given-names>G</given-names></name>, <name><surname>Tikhaze</surname><given-names>A</given-names></name>, <name><surname>Shumaev</surname><given-names>K</given-names></name>, <name><surname>Kumskova</surname><given-names>E</given-names></name>, <name><surname>Viigimaa</surname><given-names>M</given-names></name>. <article-title>The initiation of free radical peroxidation of low-density lipoproteins by glucose and its metabolite methylglyoxal: a common molecular mechanism of vascular wall injure in atherosclerosis and diabetes</article-title>. <source/>Mol Cell Biochem. <year>2014</year>;<volume>395</volume>(<issue>1-2</issue>):<fpage>241</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-014-2131-2</pub-id>
<pub-id pub-id-type="pmid">24997046</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref027">
<label>27</label>
<mixed-citation publication-type="journal">
<name><surname>Lankin</surname><given-names>V</given-names></name>, <name><surname>Tikhaze</surname><given-names>A</given-names></name>, <name><surname>Kapel’ko</surname><given-names>V</given-names></name>, <name><surname>Shepel’kova</surname><given-names>G</given-names></name>, <name><surname>Shumaev</surname><given-names>K</given-names></name>, <name><surname>Panasenko</surname><given-names>O</given-names></name>, <etal>et al</etal>
<article-title>Mechanisms of oxidative modification of low density lipoproteins under conditions of oxidative and carbonyl stress</article-title>. <source/>Biochemistry (Moscow). <year>2007</year>;<volume>72</volume>(<issue>10</issue>):<fpage>1081</fpage>–<lpage>1090</lpage>. <pub-id pub-id-type="doi">10.1134/S0006297907100069</pub-id><pub-id pub-id-type="pmid">18021066</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref028">
<label>28</label>
<mixed-citation publication-type="journal">
<name><surname>Khlebus</surname><given-names>EY</given-names></name>, <name><surname>Meshkov</surname><given-names>AN</given-names></name>, <name><surname>Lankin</surname><given-names>VZ</given-names></name>, <name><surname>Orlovsky</surname><given-names>AA</given-names></name>, <name><surname>Kiseleva</surname><given-names>AV</given-names></name>, <name><surname>Shcherbakova</surname><given-names>NV</given-names></name>, <etal>et al</etal>
<article-title>Lipid profile and genetic markers associated with the level of oxidized low density lipoproteides</article-title>. <source/>Russian Journal of Cardiology. <year>2017</year>;<volume>10</volume>(<issue>150</issue>):<fpage>49</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.15829/1560-4071-2017-10-49-54</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref029">
<label>29</label>
<mixed-citation publication-type="journal">
<name><surname>Friedewald</surname><given-names>WT</given-names></name>, <name><surname>Levy</surname><given-names>RI</given-names></name>, <name><surname>Fredrickson</surname><given-names>DS</given-names></name>. <article-title>Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge</article-title>. <source/>Clin Chem. <year>1972</year>;<volume>18</volume>(<issue>6</issue>):<fpage>499</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="pmid">4337382</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref030">
<label>30</label>
<mixed-citation publication-type="journal">
<name><surname>Ershova</surname><given-names>AI</given-names></name>, <name><surname>Balakhonova</surname><given-names>TV</given-names></name>, <name><surname>Meshkov</surname><given-names>AN</given-names></name>, <name><surname>Rozhkova</surname><given-names>TA</given-names></name>, <name><surname>Boytsov</surname><given-names>SA</given-names></name>. <article-title>Ultrasound markers that describe plaques are more sensitive than mean intima-media thickness in patients with familial hypercholesterolemia</article-title>. <source/>Ultrasound Med Biol. <year>2012</year>;<volume>38</volume>(<issue>3</issue>):<fpage>417</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1016/j.ultrasmedbio.2011.11.014</pub-id>
<pub-id pub-id-type="pmid">22261515</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref031">
<label>31</label>
<mixed-citation publication-type="journal">
<name><surname>Touboul</surname><given-names>PJ</given-names></name>, <name><surname>Hennerici</surname><given-names>MG</given-names></name>, <name><surname>Meairs</surname><given-names>S</given-names></name>, <name><surname>Adams</surname><given-names>H</given-names></name>, <name><surname>Amarenco</surname><given-names>P</given-names></name>, <name><surname>Desvarieux</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Mannheim intima-media thickness consensus</article-title>. <source/>Cerebrovasc Dis. <year>2004</year>;<volume>18</volume>(<issue>4</issue>):<fpage>346</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1159/000081812</pub-id>
<pub-id pub-id-type="pmid">15523176</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref032">
<label>32</label>
<mixed-citation publication-type="journal">
<name><surname>Purcell</surname><given-names>S</given-names></name>, <name><surname>Neale</surname><given-names>B</given-names></name>, <name><surname>Todd-Brown</surname><given-names>K</given-names></name>, <name><surname>Thomas</surname><given-names>L</given-names></name>, <name><surname>Ferreira</surname><given-names>MA</given-names></name>, <name><surname>Bender</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>. <source/>Am J Hum Genet. <year>2007</year>;<volume>81</volume>(<issue>3</issue>):<fpage>559</fpage>–<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1086/519795</pub-id>
<pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref033">
<label>33</label>
<mixed-citation publication-type="journal">
<name><surname>Ning</surname><given-names>Z</given-names></name>, <name><surname>Cox</surname><given-names>AJ</given-names></name>, <name><surname>Mullikin</surname><given-names>JC</given-names></name>. <article-title>SSAHA: a fast search method for large DNA databases</article-title>. <source/>Genome Res. <year>2001</year>;<volume>11</volume>(<issue>10</issue>):<fpage>1725</fpage>–<lpage>1729</lpage>. <pub-id pub-id-type="doi">10.1101/gr.194201</pub-id>
<pub-id pub-id-type="pmid">11591649</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref034">
<label>34</label>
<mixed-citation publication-type="journal">
<name><surname>Li</surname><given-names>H</given-names></name>, <name><surname>Handsaker</surname><given-names>B</given-names></name>, <name><surname>Wysoker</surname><given-names>A</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <name><surname>Ruan</surname><given-names>J</given-names></name>, <name><surname>Homer</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>The sequence alignment/map format and SAMtools</article-title>. <source/>Bioinformatics. <year>2009</year>;<volume>25</volume>(<issue>16</issue>):<fpage>2078</fpage>–<lpage>2079</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
<pub-id pub-id-type="pmid">19505943</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref035">
<label>35</label>
<mixed-citation publication-type="journal">
<name><surname>Quinlan</surname><given-names>AR</given-names></name>, <name><surname>Hall</surname><given-names>IM</given-names></name>. <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source/>Bioinformatics. <year>2010</year>;<volume>26</volume>(<issue>6</issue>):<fpage>841</fpage>–<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id>
<pub-id pub-id-type="pmid">20110278</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref036">
<label>36</label>
<mixed-citation publication-type="journal">
<name><surname>Ewing</surname><given-names>B</given-names></name>, <name><surname>Hillier</surname><given-names>L</given-names></name>, <name><surname>Wendl</surname><given-names>MC</given-names></name>, <name><surname>Green</surname><given-names>P</given-names></name>. <article-title>Base-calling of automated sequencer traces using Phred. I. Accuracy assessment</article-title>. <source/>Genome Res. <year>1998</year>;<volume>8</volume>(<issue>3</issue>):<fpage>175</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1101/gr.8.3.175</pub-id>
<pub-id pub-id-type="pmid">9521921</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref037">
<label>37</label>
<mixed-citation publication-type="journal">
<name><surname>Wang</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Hakonarson</surname><given-names>H</given-names></name>. <article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source/>Nucleic Acids Res. <year>2010</year>;<volume>38</volume>(<issue>16</issue>):<fpage>e164</fpage>
<pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>
<pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref038">
<label>38</label>
<mixed-citation publication-type="journal">
<name><surname>Kumar</surname><given-names>P</given-names></name>, <name><surname>Henikoff</surname><given-names>S</given-names></name>, <name><surname>Ng</surname><given-names>PC</given-names></name>. <article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title>. <source/>Nat Protoc. <year>2009</year>;<volume>4</volume>(<issue>7</issue>):<fpage>1073</fpage>–<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2009.86</pub-id>
<pub-id pub-id-type="pmid">19561590</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref039">
<label>39</label>
<mixed-citation publication-type="journal">
<name><surname>Adzhubei</surname><given-names>IA</given-names></name>, <name><surname>Schmidt</surname><given-names>S</given-names></name>, <name><surname>Peshkin</surname><given-names>L</given-names></name>, <name><surname>Ramensky</surname><given-names>VE</given-names></name>, <name><surname>Gerasimova</surname><given-names>A</given-names></name>, <name><surname>Bork</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>A method and server for predicting damaging missense mutations</article-title>. <source/>Nat Methods. <year>2010</year>;<volume>7</volume>(<issue>4</issue>):<fpage>248</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>
<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref040">
<label>40</label>
<mixed-citation publication-type="journal">
<name><surname>Edgar</surname><given-names>RC</given-names></name>. <article-title>MUSCLE: multiple sequence alignment with high accuracy and high throughput</article-title>. <source/>Nucleic Acids Res. <year>2004</year>;<volume>32</volume>(<issue>5</issue>):<fpage>1792</fpage>–<lpage>1797</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh340</pub-id>
<pub-id pub-id-type="pmid">15034147</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref041">
<label>41</label>
<mixed-citation publication-type="journal">
<name><surname>Waterhouse</surname><given-names>AM</given-names></name>, <name><surname>Procter</surname><given-names>JB</given-names></name>, <name><surname>Martin</surname><given-names>DM</given-names></name>, <name><surname>Clamp</surname><given-names>M</given-names></name>, <name><surname>Barton</surname><given-names>GJ</given-names></name>. <article-title>Jalview Version 2–a multiple sequence alignment editor and analysis workbench</article-title>. <source/>Bioinformatics. <year>2009</year>;<volume>25</volume>(<issue>9</issue>):<fpage>1189</fpage>–<lpage>1191</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp033</pub-id>
<pub-id pub-id-type="pmid">19151095</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref042">
<label>42</label>
<mixed-citation publication-type="other">Lee S, Miropolsky L, Wu M. Skat: Snp-Set (Sequence) Kernel Association Test R package version 1.1. 2; 2015.</mixed-citation>
</ref>
<ref id="pone.0217620.ref043">
<label>43</label>
<mixed-citation publication-type="journal">
<name><surname>Malovini</surname><given-names>A</given-names></name>, <name><surname>Bellazzi</surname><given-names>R</given-names></name>, <name><surname>Napolitano</surname><given-names>C</given-names></name>, <name><surname>Guffanti</surname><given-names>G</given-names></name>. <article-title>Multivariate methods for genetic variants selection and risk prediction in cardiovascular diseases</article-title>. <source/>Front Cardiovasc Med. <year>2016</year>;<volume>3</volume>:<fpage>17</fpage>
<pub-id pub-id-type="doi">10.3389/fcvm.2016.00017</pub-id>
<pub-id pub-id-type="pmid">27376073</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref044">
<label>44</label>
<mixed-citation publication-type="journal">
<name><surname>Zou</surname><given-names>H</given-names></name>, <name><surname>Hastie</surname><given-names>T</given-names></name>. <article-title>Regularization and variable selection via the elastic net</article-title>. <source/>J R Statist Soc B. <year>2005</year>;<volume>67</volume>(<issue>2</issue>):<fpage>301</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1111/j.1467-9868.2005.00503.x</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref045">
<label>45</label>
<mixed-citation publication-type="journal">
<name><surname>Friedman</surname><given-names>J</given-names></name>, <name><surname>Hastie</surname><given-names>T</given-names></name>, <name><surname>Tibshirani</surname><given-names>R</given-names></name>. <article-title>glmnet: Lasso and elastic-net regularized generalized linear models</article-title>. <source/>R package version. <year>2009</year>;<volume>1</volume>(<issue>4</issue>).</mixed-citation>
</ref>
<ref id="pone.0217620.ref046">
<label>46</label>
<mixed-citation publication-type="journal">
<name><surname>Pruim</surname><given-names>RJ</given-names></name>, <name><surname>Welch</surname><given-names>RP</given-names></name>, <name><surname>Sanna</surname><given-names>S</given-names></name>, <name><surname>Teslovich</surname><given-names>TM</given-names></name>, <name><surname>Chines</surname><given-names>PS</given-names></name>, <name><surname>Gliedt</surname><given-names>TP</given-names></name>, <etal>et al</etal>
<article-title>LocusZoom: regional visualization of genome-wide association scan results</article-title>. <source/>Bioinformatics. <year>2010</year>;<volume>26</volume>(<issue>18</issue>):<fpage>2336</fpage>–<lpage>2337</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btq419</pub-id>
<pub-id pub-id-type="pmid">20634204</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref047">
<label>47</label>
<mixed-citation publication-type="journal">
<name><surname>Edmondson</surname><given-names>AC</given-names></name>, <name><surname>Braund</surname><given-names>PS</given-names></name>, <name><surname>Stylianou</surname><given-names>IM</given-names></name>, <name><surname>Khera</surname><given-names>AV</given-names></name>, <name><surname>Nelson</surname><given-names>CP</given-names></name>, <name><surname>Wolfe</surname><given-names>ML</given-names></name>, <etal>et al</etal>
<article-title>Dense genotyping of candidate gene loci identifies variants associated with high-density lipoprotein cholesterol</article-title>. <source/>Circ Cardiovasc Genet. <year>2011</year>;<volume>4</volume>(<issue>2</issue>):<fpage>145</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.110.957563</pub-id>
<pub-id pub-id-type="pmid">21303902</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref048">
<label>48</label>
<mixed-citation publication-type="journal">
<name><surname>Reynolds</surname><given-names>CA</given-names></name>, <name><surname>Hong</surname><given-names>MG</given-names></name>, <name><surname>Eriksson</surname><given-names>UK</given-names></name>, <name><surname>Blennow</surname><given-names>K</given-names></name>, <name><surname>Wiklund</surname><given-names>F</given-names></name>, <name><surname>Johansson</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk</article-title>. <source/>Hum Mol Genet. <year>2010</year>;<volume>19</volume>(<issue>10</issue>):<fpage>2068</fpage>–<lpage>2078</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq079</pub-id>
<pub-id pub-id-type="pmid">20167577</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref049">
<label>49</label>
<mixed-citation publication-type="journal">
<name><surname>Prus</surname><given-names>Y</given-names></name>, <name><surname>Sergienko</surname><given-names>I</given-names></name>, <name><surname>Malyshev</surname><given-names>P</given-names></name>, <name><surname>Komar</surname><given-names>O</given-names></name>, <name><surname>Popova</surname><given-names>A</given-names></name>, <name><surname>NA</surname><given-names>S</given-names></name>. <article-title>A rare genetic mutation in patients with heterozygous familial hypercholesterolemia</article-title>. <source/>Atherosclerosis and Dyslipidaemias. <year>2017</year>;<volume>2</volume>(<issue>27</issue>):<fpage>84</fpage>–<lpage>90</lpage>.</mixed-citation>
</ref>
<ref id="pone.0217620.ref050">
<label>50</label>
<mixed-citation publication-type="journal">
<name><surname>Teslovich</surname><given-names>TM</given-names></name>, <name><surname>Musunuru</surname><given-names>K</given-names></name>, <name><surname>Smith</surname><given-names>AV</given-names></name>, <name><surname>Edmondson</surname><given-names>AC</given-names></name>, <name><surname>Stylianou</surname><given-names>IM</given-names></name>, <name><surname>Koseki</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Biological, clinical and population relevance of 95 loci for blood lipids</article-title>. <source/>Nature. <year>2010</year>;<volume>466</volume>(<issue>7307</issue>):<fpage>707</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1038/nature09270</pub-id>
<pub-id pub-id-type="pmid">20686565</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref051">
<label>51</label>
<mixed-citation publication-type="journal">
<name><surname>Benn</surname><given-names>M</given-names></name>, <name><surname>Stene</surname><given-names>MC</given-names></name>, <name><surname>Nordestgaard</surname><given-names>BG</given-names></name>, <name><surname>Jensen</surname><given-names>GB</given-names></name>, <name><surname>Steffensen</surname><given-names>R</given-names></name>, <name><surname>Tybjærg-Hansen</surname><given-names>A</given-names></name>. <article-title>Common and rare alleles in apolipoprotein B contribute to plasma levels of low-density lipoprotein cholesterol in the general population</article-title>. <source/>J Clin Endocrinol Metab. <year>2008</year>;<volume>93</volume>(<issue>3</issue>):<fpage>1038</fpage>–<lpage>1045</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2007-1365</pub-id>
<pub-id pub-id-type="pmid">18160469</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref052">
<label>52</label>
<mixed-citation publication-type="journal">
<name><surname>Bryant</surname><given-names>EK</given-names></name>, <name><surname>Dressen</surname><given-names>AS</given-names></name>, <name><surname>Bunker</surname><given-names>CH</given-names></name>, <name><surname>Hokanson</surname><given-names>JE</given-names></name>, <name><surname>Hamman</surname><given-names>RF</given-names></name>, <name><surname>Kamboh</surname><given-names>MI</given-names></name>, <etal>et al</etal>
<article-title>A multiethnic replication study of plasma lipoprotein levels-associated SNPs identified in recent GWAS</article-title>. <source/>PLoS One. <year>2013</year>;<volume>8</volume>(<issue>5</issue>):<fpage>e63469</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0063469</pub-id>
<pub-id pub-id-type="pmid">23717430</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref053">
<label>53</label>
<mixed-citation publication-type="journal">
<name><surname>Tukiainen</surname><given-names>T</given-names></name>, <name><surname>Kettunen</surname><given-names>J</given-names></name>, <name><surname>Kangas</surname><given-names>AJ</given-names></name>, <name><surname>Lyytikäinen</surname><given-names>LP</given-names></name>, <name><surname>Soininen</surname><given-names>P</given-names></name>, <name><surname>Sarin</surname><given-names>AP</given-names></name>, <etal>et al</etal>
<article-title>Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci</article-title>. <source/>Hum Mol Genet. <year>2012</year>;<volume>21</volume>(<issue>6</issue>):<fpage>1444</fpage>–<lpage>1455</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr581</pub-id>
<pub-id pub-id-type="pmid">22156771</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref054">
<label>54</label>
<mixed-citation publication-type="journal">
<name><surname>Zhou</surname><given-names>F</given-names></name>, <name><surname>Guo</surname><given-names>T</given-names></name>, <name><surname>Zhou</surname><given-names>L</given-names></name>, <name><surname>Zhou</surname><given-names>Y</given-names></name>, <name><surname>Yu</surname><given-names>D</given-names></name>. <article-title>Variants in the APOB gene was associated with Ischemic Stroke susceptibility in Chinese Han male population</article-title>. <source/>Oncotarget. <year>2018</year>;<volume>9</volume>(<issue>2</issue>):<fpage>2249</fpage>–<lpage>2254</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.23369</pub-id>
<pub-id pub-id-type="pmid">29416768</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref055">
<label>55</label>
<mixed-citation publication-type="journal">
<name><surname>Gu</surname><given-names>QL</given-names></name>, <name><surname>Han</surname><given-names>Y</given-names></name>, <name><surname>Lan</surname><given-names>YM</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Kou</surname><given-names>W</given-names></name>, <name><surname>Zhou</surname><given-names>YS</given-names></name>, <etal>et al</etal>
<article-title>Association between polymorphisms in the APOB gene and hyperlipidemia in the Chinese Yugur population</article-title>. <source/>Braz J Med Biol Res. <year>2017</year>;<volume>50</volume>(<issue>11</issue>):<fpage>e6613</fpage>
<pub-id pub-id-type="doi">10.1590/1414-431X20176613</pub-id>
<pub-id pub-id-type="pmid">28902930</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref056">
<label>56</label>
<mixed-citation publication-type="journal">
<name><surname>Kim</surname><given-names>DS</given-names></name>, <name><surname>Burt</surname><given-names>AA</given-names></name>, <name><surname>Ranchalis</surname><given-names>JE</given-names></name>, <name><surname>Jarvik</surname><given-names>ER</given-names></name>, <name><surname>Rosenthal</surname><given-names>EA</given-names></name>, <name><surname>Hatsukami</surname><given-names>TS</given-names></name>, <etal>et al</etal>
<article-title>Novel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol</article-title>. <source/>J Lipid Res. <year>2013</year>;<volume>54</volume>(<issue>5</issue>):<fpage>1512</fpage>–<lpage>1520</lpage>. <pub-id pub-id-type="doi">10.1194/jlr.P035238</pub-id>
<pub-id pub-id-type="pmid">23482652</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref057">
<label>57</label>
<mixed-citation publication-type="journal">
<name><surname>Kulminski</surname><given-names>AM</given-names></name>, <name><surname>Culminskaya</surname><given-names>I</given-names></name>, <name><surname>Arbeev</surname><given-names>KG</given-names></name>, <name><surname>Ukraintseva</surname><given-names>SV</given-names></name>, <name><surname>Stallard</surname><given-names>E</given-names></name>, <name><surname>Arbeeva</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>The role of lipid-related genes, aging-related processes, and environment in healthspan</article-title>. <source/>Aging Cell. <year>2013</year>;<volume>12</volume>(<issue>2</issue>):<fpage>237</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12046</pub-id>
<pub-id pub-id-type="pmid">23320904</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref058">
<label>58</label>
<mixed-citation publication-type="journal">
<name><surname>Liao</surname><given-names>YC</given-names></name>, <name><surname>Lin</surname><given-names>HF</given-names></name>, <name><surname>Rundek</surname><given-names>T</given-names></name>, <name><surname>Cheng</surname><given-names>R</given-names></name>, <name><surname>Hsi</surname><given-names>E</given-names></name>, <name><surname>Sacco</surname><given-names>RL</given-names></name>, <etal>et al</etal>
<article-title>Multiple genetic determinants of plasma lipid levels in Caribbean Hispanics</article-title>. <source/>Clin Biochem. <year>2008</year>;<volume>41</volume>(<issue>4-5</issue>):<fpage>306</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinbiochem.2007.11.011</pub-id>
<pub-id pub-id-type="pmid">18078817</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref059">
<label>59</label>
<mixed-citation publication-type="journal">
<name><surname>Radovica-Spalvina</surname><given-names>I</given-names></name>, <name><surname>Latkovskis</surname><given-names>G</given-names></name>, <name><surname>Silamikelis</surname><given-names>I</given-names></name>, <name><surname>Fridmanis</surname><given-names>D</given-names></name>, <name><surname>Elbere</surname><given-names>I</given-names></name>, <name><surname>Ventins</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL–C levels in a latvian population</article-title>. <source/>BMC Med Genet. <year>2015</year>;<volume>16</volume>(<issue>1</issue>):<fpage>86</fpage>
<pub-id pub-id-type="doi">10.1186/s12881-015-0230-x</pub-id>
<pub-id pub-id-type="pmid">26415676</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref060">
<label>60</label>
<mixed-citation publication-type="journal">
<name><surname>Huijgen</surname><given-names>R</given-names></name>, <name><surname>Sjouke</surname><given-names>B</given-names></name>, <name><surname>Vis</surname><given-names>K</given-names></name>, <name><surname>de Randamie</surname><given-names>JS</given-names></name>, <name><surname>Defesche</surname><given-names>JC</given-names></name>, <name><surname>Kastelein</surname><given-names>JJ</given-names></name>, <etal>et al</etal>
<article-title>Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels</article-title>. <source/>Hum Mutat. <year>2012</year>;<volume>33</volume>(<issue>2</issue>):<fpage>448</fpage>–<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21660</pub-id>
<pub-id pub-id-type="pmid">22095935</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref061">
<label>61</label>
<mixed-citation publication-type="journal">
<name><surname>Starcevic</surname><given-names>JN</given-names></name>, <name><surname>Letonja</surname><given-names>MS</given-names></name>, <name><surname>Praznikar</surname><given-names>ZJ</given-names></name>, <name><surname>Makuc</surname><given-names>J</given-names></name>, <name><surname>Vujkovac</surname><given-names>AC</given-names></name>, <name><surname>Petrovic</surname><given-names>D</given-names></name>. <article-title>Polymorphisms XbaI (rs693) and EcoRI (rs1042031) of the ApoB gene are associated with carotid plaques but not with carotid intima-media thickness in patients with diabetes mellitus type 2</article-title>. <source/>Vasa. <year>2014</year>;<volume>43</volume>(<issue>3</issue>):<fpage>171</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1024/0301-1526/a000346</pub-id><pub-id pub-id-type="pmid">24797048</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref062">
<label>62</label>
<mixed-citation publication-type="journal">
<name><surname>Ríos-González</surname><given-names>BE</given-names></name>, <name><surname>Ibarra-Cortés</surname><given-names>B</given-names></name>, <name><surname>Ramírez-López</surname><given-names>G</given-names></name>, <name><surname>Sánchez-Corona</surname><given-names>J</given-names></name>, <name><surname>Magaña-Torres</surname><given-names>MT</given-names></name>. <article-title>Association of polymorphisms of genes involved in lipid metabolism with blood pressure and lipid values in mexican hypertensive individuals</article-title>. <source/>Dis Markers. <year>2014</year>;<volume>2014</volume>:<fpage>150358</fpage>
<pub-id pub-id-type="doi">10.1155/2014/150358</pub-id>
<pub-id pub-id-type="pmid">25587205</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref063">
<label>63</label>
<mixed-citation publication-type="journal">
<name><surname>Al-Bustan</surname><given-names>SA</given-names></name>, <name><surname>Alnaqeeb</surname><given-names>MA</given-names></name>, <name><surname>Annice</surname><given-names>BG</given-names></name>, <name><surname>Ebrahim</surname><given-names>GA</given-names></name>, <name><surname>Refai</surname><given-names>TM</given-names></name>. <article-title>Genetic association of APOB polymorphisms with variation in serum lipid profile among the Kuwait population</article-title>. <source/>Lipids Health Dis. <year>2014</year>;<volume>13</volume>(<issue>1</issue>):<fpage>157</fpage>
<pub-id pub-id-type="doi">10.1186/1476-511X-13-157</pub-id>
<pub-id pub-id-type="pmid">25292352</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref064">
<label>64</label>
<mixed-citation publication-type="journal">
<name><surname>Chiou</surname><given-names>KR</given-names></name>, <name><surname>Charng</surname><given-names>MJ</given-names></name>. <article-title>Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China</article-title>. <source/>Gene. <year>2012</year>;<volume>498</volume>(<issue>1</issue>):<fpage>100</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2012.01.092</pub-id>
<pub-id pub-id-type="pmid">22353362</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref065">
<label>65</label>
<mixed-citation publication-type="journal">
<name><surname>Muiya</surname><given-names>P</given-names></name>, <name><surname>Wakil</surname><given-names>S</given-names></name>, <name><surname>Al-Najai</surname><given-names>M</given-names></name>, <name><surname>Meyer</surname><given-names>BF</given-names></name>, <name><surname>Al-Mohanna</surname><given-names>F</given-names></name>, <name><surname>Alshahid</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Identification of loci conferring risk for premature CAD and heterozygous familial hyperlipidemia in the LDLR, APOB and PCSK9 genes</article-title>. <source/>Int J Diabetes Mellit. <year>2009</year>;<volume>1</volume>(<issue>1</issue>):<fpage>16</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdm.2009.05.003</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref066">
<label>66</label>
<mixed-citation publication-type="journal">
<name><surname>Gu</surname><given-names>W</given-names></name>, <name><surname>Zhang</surname><given-names>M</given-names></name>, <name><surname>Wen</surname><given-names>S</given-names></name>. <article-title>Association between the APOB XbaI and EcoRI polymorphisms and lipids in Chinese: a meta-analysis</article-title>. <source/>Lipids Health Dis. <year>2015</year>;<volume>14</volume>(<issue>1</issue>):<fpage>123</fpage>
<pub-id pub-id-type="doi">10.1186/s12944-015-0125-z</pub-id>
<pub-id pub-id-type="pmid">26446158</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref067">
<label>67</label>
<mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Qu</surname><given-names>H</given-names></name>, <name><surname>Hou</surname><given-names>M</given-names></name>, <name><surname>Cao</surname><given-names>W</given-names></name>, <name><surname>Ma</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>Associations of polymorphisms of rs693 and rs1042031 in apolipoprotein B gene with risk of breast cancer in Chinese</article-title>. <source/>Jpn J Clin Oncol. <year>2013</year>;<volume>43</volume>(<issue>4</issue>):<fpage>362</fpage>–<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1093/jjco/hyt018</pub-id>
<pub-id pub-id-type="pmid">23444115</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref068">
<label>68</label>
<mixed-citation publication-type="journal">
<name><surname>Au</surname><given-names>A</given-names></name>, <name><surname>Griffiths</surname><given-names>LR</given-names></name>, <name><surname>Irene</surname><given-names>L</given-names></name>, <name><surname>Kooi</surname><given-names>CW</given-names></name>, <name><surname>Wei</surname><given-names>LK</given-names></name>. <article-title>The impact of APOA5, APOB, APOC3 and ABCA1 gene polymorphisms on ischemic stroke: Evidence from a meta-analysis</article-title>. <source/>Atherosclerosis. <year>2017</year>;<volume>265</volume>:<fpage>60</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2017.08.003</pub-id>
<pub-id pub-id-type="pmid">28865324</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref069">
<label>69</label>
<mixed-citation publication-type="journal">
<name><surname>Cash</surname><given-names>TP</given-names></name>, <name><surname>Pita</surname><given-names>G</given-names></name>, <name><surname>Domínguez</surname><given-names>O</given-names></name>, <name><surname>Alonso</surname><given-names>MR</given-names></name>, <name><surname>Moreno</surname><given-names>LT</given-names></name>, <name><surname>Borras</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Exome sequencing of three cases of familial exceptional longevity</article-title>. <source/>Aging Cell. <year>2014</year>;<volume>13</volume>(<issue>6</issue>):<fpage>1087</fpage>–<lpage>1090</lpage>. <pub-id pub-id-type="doi">10.1111/acel.12261</pub-id>
<pub-id pub-id-type="pmid">25116423</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref070">
<label>70</label>
<mixed-citation publication-type="journal">
<name><surname>Ung</surname><given-names>C</given-names></name>, <name><surname>Sanchez</surname><given-names>AV</given-names></name>, <name><surname>Shen</surname><given-names>L</given-names></name>, <name><surname>Davoudi</surname><given-names>S</given-names></name>, <name><surname>Ahmadi</surname><given-names>T</given-names></name>, <name><surname>Navarro-Gomez</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy</article-title>. <source/>Vision Res. <year>2017</year>;<volume>139</volume>:<fpage>168</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.visres.2017.03.007</pub-id>
<pub-id pub-id-type="pmid">28431867</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref071">
<label>71</label>
<mixed-citation publication-type="journal">
<name><surname>Xiao</surname><given-names>D</given-names></name>, <name><surname>Huang</surname><given-names>K</given-names></name>, <name><surname>Chen</surname><given-names>Q</given-names></name>, <name><surname>Huang</surname><given-names>B</given-names></name>, <name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Peng</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Four Apolipoprotein B gene polymorphisms and the risk for coronary artery disease: a meta-analysis of 47 studies</article-title>. <source/>Genes &amp; Genomics. <year>2015</year>;<volume>37</volume>(<issue>7</issue>):<fpage>621</fpage>–<lpage>632</lpage>. <pub-id pub-id-type="doi">10.1007/s13258-015-0292-3</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref072">
<label>72</label>
<mixed-citation publication-type="journal">
<name><surname>Gaffney</surname><given-names>D</given-names></name>, <name><surname>Hoffs</surname><given-names>MS</given-names></name>, <name><surname>Cameron</surname><given-names>IM</given-names></name>, <name><surname>Stewart</surname><given-names>G</given-names></name>, <name><surname>O’Reilly</surname><given-names>DSJ</given-names></name>, <name><surname>Packard</surname><given-names>CJ</given-names></name>. <article-title>Influence of polymorphism Q3405E and mutation A3371V in the apolipoprotein B gene on LDL receptor binding</article-title>. <source/>Atherosclerosis. <year>1998</year>;<volume>137</volume>(<issue>1</issue>):<fpage>167</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/S0021-9150(97)00242-6</pub-id>
<pub-id pub-id-type="pmid">9568749</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref073">
<label>73</label>
<mixed-citation publication-type="journal">
<name><surname>Pullinger</surname><given-names>CR</given-names></name>, <name><surname>Love</surname><given-names>JA</given-names></name>, <name><surname>Liu</surname><given-names>W</given-names></name>, <name><surname>Hennessy</surname><given-names>LK</given-names></name>, <name><surname>Ghassemzadeh</surname><given-names>M</given-names></name>, <name><surname>Newcomb</surname><given-names>KC</given-names></name>, <etal>et al</etal>
<article-title>The apolipoprotein B Q3405E polymorphism has no effect on its low-density-lipoprotein receptor binding affinity</article-title>. <source/>Hum Genet. <year>1996</year>;<volume>98</volume>(<issue>6</issue>):<fpage>678</fpage>–<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1007/s004390050283</pub-id>
<pub-id pub-id-type="pmid">8931699</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref074">
<label>74</label>
<mixed-citation publication-type="journal">
<name><surname>Maurer</surname><given-names>F</given-names></name>, <name><surname>Pradervand</surname><given-names>S</given-names></name>, <name><surname>Guilleret</surname><given-names>I</given-names></name>, <name><surname>Nanchen</surname><given-names>D</given-names></name>, <name><surname>Maghraoui</surname><given-names>A</given-names></name>, <name><surname>Chapatte</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Identification and molecular characterisation of Lausanne Institutional Biobank participants with familial hypercholesterolaemia–a proof-of-concept study</article-title>. <source/>Swiss Med Wkly. <year>2016</year>;<volume>146</volume>:<fpage>w14326</fpage>
<pub-id pub-id-type="doi">10.4414/smw.2016.14326</pub-id>
<pub-id pub-id-type="pmid">27497240</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref075">
<label>75</label>
<mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>C</given-names></name>, <name><surname>Yang</surname><given-names>J</given-names></name>, <name><surname>Han</surname><given-names>W</given-names></name>, <name><surname>Zhang</surname><given-names>Q</given-names></name>, <name><surname>Shang</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>Polymorphisms in ApoB gene are associated with risk of myocardial infarction and serum ApoB levels in a Chinese population</article-title>. <source/>Int J Clin Exp Med. <year>2015</year>;<volume>8</volume>(<issue>9</issue>):<fpage>16571</fpage>–<lpage>16577</lpage>. <pub-id pub-id-type="pmid">26629186</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref076">
<label>76</label>
<mixed-citation publication-type="journal">
<name><surname>Chasman</surname><given-names>DI</given-names></name>, <name><surname>Paré</surname><given-names>G</given-names></name>, <name><surname>Mora</surname><given-names>S</given-names></name>, <name><surname>Hopewell</surname><given-names>JC</given-names></name>, <name><surname>Peloso</surname><given-names>G</given-names></name>, <name><surname>Clarke</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Forty-Three Loci Associated with Plasma Lipoprotein Size, Concentration, and Cholesterol Content in Genome-Wide Analysis</article-title>. <source/>PLoS Genet. <year>2009</year>;<volume>5</volume>(<issue>11</issue>):<fpage>e1000730</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000730</pub-id>
<pub-id pub-id-type="pmid">19936222</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref077">
<label>77</label>
<mixed-citation publication-type="journal">
<name><surname>Chu</surname><given-names>AY</given-names></name>, <name><surname>Guilianini</surname><given-names>F</given-names></name>, <name><surname>Grallert</surname><given-names>H</given-names></name>, <name><surname>Dupuis</surname><given-names>J</given-names></name>, <name><surname>Ballantyne</surname><given-names>CM</given-names></name>, <name><surname>Barratt</surname><given-names>BJ</given-names></name>, <etal>et al</etal>
<article-title>Genome-Wide Association Study Evaluating Lp-PLA2 Mass and Activity at Baseline and Following Rosuvastatin Therapy</article-title>. <source/>Circ Cardiovasc Genet. <year>2012</year>;<volume>5</volume>(<issue>6</issue>):<fpage>676</fpage>–<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.112.963314</pub-id>
<pub-id pub-id-type="pmid">23118302</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref078">
<label>78</label>
<mixed-citation publication-type="journal">
<name><surname>Sabatti</surname><given-names>C</given-names></name>, <name><surname>Hartikainen</surname><given-names>AL</given-names></name>, <name><surname>Pouta</surname><given-names>A</given-names></name>, <name><surname>Ripatti</surname><given-names>S</given-names></name>, <name><surname>Brodsky</surname><given-names>J</given-names></name>, <name><surname>Jones</surname><given-names>CG</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide association analysis of metabolic traits in a birth cohort from a founder population</article-title>. <source/>Nat Genet. <year>2009</year>;<volume>41</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1038/ng.271</pub-id>
<pub-id pub-id-type="pmid">19060910</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref079">
<label>79</label>
<mixed-citation publication-type="journal">
<name><surname>Aulchenko</surname><given-names>YS</given-names></name>, <name><surname>Ripatti</surname><given-names>S</given-names></name>, <name><surname>Lindqvist</surname><given-names>I</given-names></name>, <name><surname>Boomsma</surname><given-names>D</given-names></name>, <name><surname>Heid</surname><given-names>IM</given-names></name>, <name><surname>Pramstaller</surname><given-names>PP</given-names></name>, <etal>et al</etal>
<article-title>Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts</article-title>. <source/>Nat Genet. <year>2009</year>;<volume>41</volume>(<issue>1</issue>):<fpage>47</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1038/ng.269</pub-id>
<pub-id pub-id-type="pmid">19060911</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref080">
<label>80</label>
<mixed-citation publication-type="journal">
<name><surname>Kathiresan</surname><given-names>S</given-names></name>, <name><surname>Melander</surname><given-names>O</given-names></name>, <name><surname>Guiducci</surname><given-names>C</given-names></name>, <name><surname>Surti</surname><given-names>A</given-names></name>, <name><surname>Burtt</surname><given-names>NP</given-names></name>, <name><surname>Rieder</surname><given-names>MJ</given-names></name>, <etal>et al</etal>
<article-title>Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans</article-title>. <source/>Nat Genet. <year>2008</year>;<volume>40</volume>(<issue>2</issue>):<fpage>189</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1038/ng.75</pub-id>
<pub-id pub-id-type="pmid">18193044</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref081">
<label>81</label>
<mixed-citation publication-type="journal">
<name><surname>Saxena</surname><given-names>R</given-names></name>, <name><surname>Voight</surname><given-names>BF</given-names></name>, <name><surname>Lyssenko</surname><given-names>V</given-names></name>, <name><surname>Burtt</surname><given-names>NP</given-names></name>, <name><surname>de Bakker</surname><given-names>PI</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels</article-title>. <source/>Science. <year>2007</year>;<volume>316</volume>(<issue>5829</issue>):<fpage>1331</fpage>–<lpage>1336</lpage>. <pub-id pub-id-type="doi">10.1126/science.1142358</pub-id>
<pub-id pub-id-type="pmid">17463246</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref082">
<label>82</label>
<mixed-citation publication-type="journal">
<name><surname>Kanoni</surname><given-names>S</given-names></name>, <name><surname>Masca</surname><given-names>NG</given-names></name>, <name><surname>Stirrups</surname><given-names>KE</given-names></name>, <name><surname>Varga</surname><given-names>TV</given-names></name>, <name><surname>Warren</surname><given-names>HR</given-names></name>, <name><surname>Scott</surname><given-names>RA</given-names></name>, <etal>et al</etal>
<article-title>Analysis with the exome array identifies multiple new independent variants in lipid loci</article-title>. <source/>Hum Mol Genet. <year>2016</year>;<volume>25</volume>(<issue>18</issue>):<fpage>4094</fpage>–<lpage>4106</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw227</pub-id>
<pub-id pub-id-type="pmid">27466198</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref083">
<label>83</label>
<mixed-citation publication-type="journal">
<name><surname>Tada</surname><given-names>H</given-names></name>, <name><surname>Won</surname><given-names>HH</given-names></name>, <name><surname>Melander</surname><given-names>O</given-names></name>, <name><surname>Yang</surname><given-names>J</given-names></name>, <name><surname>Peloso</surname><given-names>GM</given-names></name>, <name><surname>Kathiresan</surname><given-names>S</given-names></name>. <article-title>Multiple associated variants increase the heritability explained for plasma lipids and coronary artery disease</article-title>. <source/>Circ Cardiovasc Genet. <year>2014</year>;<volume>7</volume>(<issue>5</issue>):<fpage>583</fpage>–<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.113.000420</pub-id>
<pub-id pub-id-type="pmid">25170055</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref084">
<label>84</label>
<mixed-citation publication-type="journal">
<name><surname>Dewey</surname><given-names>FE</given-names></name>, <name><surname>Murray</surname><given-names>MF</given-names></name>, <name><surname>Overton</surname><given-names>JD</given-names></name>, <name><surname>Habegger</surname><given-names>L</given-names></name>, <name><surname>Leader</surname><given-names>JB</given-names></name>, <name><surname>Fetterolf</surname><given-names>SN</given-names></name>, <etal>et al</etal>
<article-title>Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study</article-title>. <source/>Science. <year>2016</year>;<volume>354</volume>(<issue>6319</issue>):<fpage>aaf6814</fpage>
<pub-id pub-id-type="doi">10.1126/science.aaf6814</pub-id>
<pub-id pub-id-type="pmid">28008009</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref085">
<label>85</label>
<mixed-citation publication-type="journal">
<name><surname>Peddareddygari</surname><given-names>LR</given-names></name>, <name><surname>Grewal</surname><given-names>RP</given-names></name>. <article-title>Identification of Novel Mutations in Spatacsin and Apolipoprotein B Genes in a Patient with Spastic Paraplegia and Hypobetalipoproteinemia</article-title>. <source/>Case Rep Genet. <year>2015</year>;<volume>2015</volume>
<pub-id pub-id-type="doi">10.1155/2015/219691</pub-id>
<pub-id pub-id-type="pmid">26064709</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref086">
<label>86</label>
<mixed-citation publication-type="journal">
<name><surname>Alves</surname><given-names>AC</given-names></name>, <name><surname>Etxebarria</surname><given-names>A</given-names></name>, <name><surname>Soutar</surname><given-names>AK</given-names></name>, <name><surname>Martin</surname><given-names>C</given-names></name>, <name><surname>Bourbon</surname><given-names>M</given-names></name>. <article-title>Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia</article-title>. <source/>Hum Mol Genet. <year>2014</year>;<volume>23</volume>(<issue>7</issue>):<fpage>1817</fpage>–<lpage>1828</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt573</pub-id>
<pub-id pub-id-type="pmid">24234650</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref087">
<label>87</label>
<mixed-citation publication-type="journal">
<name><surname>Vandrovcova</surname><given-names>J</given-names></name>, <name><surname>Thomas</surname><given-names>ER</given-names></name>, <name><surname>Atanur</surname><given-names>SS</given-names></name>, <name><surname>Norsworthy</surname><given-names>PJ</given-names></name>, <name><surname>Neuwirth</surname><given-names>C</given-names></name>, <name><surname>Tan</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>The use of next-generation sequencing in clinical diagnosis of familial hypercholesterolemia</article-title>. <source/>Genet Med. <year>2013</year>;<volume>15</volume>(<issue>12</issue>):<fpage>948</fpage>–<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1038/gim.2013.55</pub-id>
<pub-id pub-id-type="pmid">23680767</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref088">
<label>88</label>
<mixed-citation publication-type="journal">
<name><surname>Yoshida</surname><given-names>T</given-names></name>, <name><surname>Kato</surname><given-names>K</given-names></name>, <name><surname>Yokoi</surname><given-names>K</given-names></name>, <name><surname>Watanabe</surname><given-names>S</given-names></name>, <name><surname>Metoki</surname><given-names>N</given-names></name>, <name><surname>Satoh</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension</article-title>. <source/>Hypertens Res. <year>2009</year>;<volume>32</volume>(<issue>5</issue>):<fpage>411</fpage>–<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1038/hr.2009.22</pub-id>
<pub-id pub-id-type="pmid">19282863</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref089">
<label>89</label>
<mixed-citation publication-type="journal">
<name><surname>Junyent</surname><given-names>M</given-names></name>, <name><surname>Tucker</surname><given-names>KL</given-names></name>, <name><surname>Shen</surname><given-names>J</given-names></name>, <name><surname>Lee</surname><given-names>YC</given-names></name>, <name><surname>Smith</surname><given-names>CE</given-names></name>, <name><surname>Mattei</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>A composite scoring of genotypes discriminates coronary heart disease risk beyond conventional risk factors in the Boston Puerto Rican Health Study</article-title>. <source/>Nutr Metab Cardiovasc Dis. <year>2010</year>;<volume>20</volume>(<issue>3</issue>):<fpage>157</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.numecd.2009.03.016</pub-id>
<pub-id pub-id-type="pmid">19501493</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref090">
<label>90</label>
<mixed-citation publication-type="journal">
<name><surname>Willer</surname><given-names>CJ</given-names></name>, <name><surname>Schmidt</surname><given-names>EM</given-names></name>, <name><surname>Sengupta</surname><given-names>S</given-names></name>, <name><surname>Peloso</surname><given-names>GM</given-names></name>, <name><surname>Gustafsson</surname><given-names>S</given-names></name>, <name><surname>Kanoni</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Discovery and refinement of loci associated with lipid levels</article-title>. <source/>Nat Genet. <year>2013</year>;<volume>45</volume>(<issue>11</issue>):<fpage>1274</fpage>–<lpage>1283</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2797</pub-id>
<pub-id pub-id-type="pmid">24097068</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref091">
<label>91</label>
<mixed-citation publication-type="journal">
<name><surname>Kotowski</surname><given-names>IK</given-names></name>, <name><surname>Pertsemlidis</surname><given-names>A</given-names></name>, <name><surname>Luke</surname><given-names>A</given-names></name>, <name><surname>Cooper</surname><given-names>RS</given-names></name>, <name><surname>Vega</surname><given-names>GL</given-names></name>, <name><surname>Cohen</surname><given-names>JC</given-names></name>, <etal>et al</etal>
<article-title>A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol</article-title>. <source/>Am J Hum Genet. <year>2006</year>;<volume>78</volume>(<issue>3</issue>):<fpage>410</fpage>–<lpage>422</lpage>. <pub-id pub-id-type="doi">10.1086/500615</pub-id>
<pub-id pub-id-type="pmid">16465619</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref092">
<label>92</label>
<mixed-citation publication-type="journal">
<name><surname>Cartegni</surname><given-names>L</given-names></name>, <name><surname>Chew</surname><given-names>SL</given-names></name>, <name><surname>Krainer</surname><given-names>AR</given-names></name>. <article-title>Listening to silence and understanding nonsense: exonic mutations that affect splicing</article-title>. <source/>Nature Reviews Genetics. <year>2002</year>;<volume>3</volume>(<issue>4</issue>):<fpage>285</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1038/nrg775</pub-id>
<pub-id pub-id-type="pmid">11967553</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref093">
<label>93</label>
<mixed-citation publication-type="journal">
<name><surname>Chamary</surname><given-names>JV</given-names></name>, <name><surname>Hurst</surname><given-names>LD</given-names></name>. <article-title>Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals</article-title>. <source/>Genome biology. <year>2005</year>;<volume>6</volume>(<issue>9</issue>):<fpage>R75</fpage>
<pub-id pub-id-type="doi">10.1186/gb-2005-6-9-r75</pub-id>
<pub-id pub-id-type="pmid">16168082</pub-id></mixed-citation>
</ref>
<ref id="pone.0217620.ref094">
<label>94</label>
<mixed-citation publication-type="journal">
<name><surname>Fernandez-Higuero</surname><given-names>JA</given-names></name>, <name><surname>Etxebarria</surname><given-names>A</given-names></name>, <name><surname>Benito-Vicente</surname><given-names>A</given-names></name>, <name><surname>Alves</surname><given-names>AC</given-names></name>, <name><surname>Arrondo</surname><given-names>JL</given-names></name>, <name><surname>Ostolaza</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity</article-title>. <source/>Sci Rep. <year>2015</year>;<volume>5</volume>:<fpage>18184</fpage>
<pub-id pub-id-type="doi">10.1038/srep18184</pub-id>
<pub-id pub-id-type="pmid">26643808</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>